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Abstract
Antimicrobial peptides (AMPs) are present in virtually every multi-cellular organism and
comprise an important component of the innate host defense system. Collectively, AMPs
have broad spectrum and selective microbicidal effects. A general mechanism of AMP ac-
tivity is destabilization of the physical integrity of cell plasma membranes leading to depo-
larization, leakage, and eventual cell death. This thesis provides a detailed molecular model
how AMPs destabilize membranes specifically, based upon their fundamental structural mo-
tif: they are amphipathic and cationic. Generic electrostatic and hydrophobic interactions
between a cationic, amphipathic AMP and a cell membrane lead to strong binding between
the peptide and membrane and subsequent partial insertion of the peptide into the bilayer.
The physical chemistry of AMPs leads to a whole taxonomy of local membrane distortions,
specific combinations of which are topologically active and can lead to membrane destabiliza-
tion. AMPs permeabilize model bacterial membranes but not model eukaryotic membranes
by selectively generating topologically active saddle-splay (‘negative Gaussian’) curvature in
membranes rich in negative curvature lipids and anionic lipids, compositions characteristic of
bacterial cell membranes. A mechanism of action based on saddle-splay membrane curvature
generation is broadly enabling, since it is a necessary condition for processes such as pore
formation, blebbing, budding, vesicularization, all of which destabilize the barrier function
of cell membranes. The topological requirement for saddle-splay curvature places constraints
on the amino acid compositions of membrane disruptive peptides. In AMPs decreasing argi-
nine content is offset by a simultaneous increase in lysine and hydrophobic content. This
‘saddle-splay curvature design rule’ is consistent with the amino acid compositions of 1,080
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known cationic AMPs. Furthermore, good correspondence is observed between membrane
curvature generation and the microbicidal profiles of prototypical AMPs, suggesting that
curvature generation is an indicator of AMP activity. Finally, this thesis concludes with
brief discussions on the possibility of other AMP design rules, as well as the presence of am-
phipathic domains in other curvature generating proteins which generate similar or distinct
curvatures to AMPs depending on their structural motifs.
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Chapter 1
Review of Lipid Membranes and
Antimicrobial Peptides
1.1 Introduction
Cell membranes are essential in biology, since cellular life requires separation of the living
material from the harsh conditions of the surrounding environment. This does not mean
they form an impenetrable barrier, however. Cells must selectively exchange material such
as nutrients, ions, waste products, and signal proteins with the medium [1, 2]. The selective
barrier function of membranes is also employed within the cell as many have a modular
design [1, 2, 3]. Eukaryotic organelles such as mitochondria, golgi, vacuoles, chloroplast,
ER, etc., are all surrounded by membranes [1, 2]. Compartmentalizing space allows the
different modules to perform their specific tasks and functions in a highly organized setting
[1, 4]. While this specialization provides better control over complex biological processes,
the modules must be synchronized and they must cooperate in order to maintain proper
cell operation [4]. The selective permeability of membranes as well as their relative ease of
transport allows them to indirectly and directly provide communication pathways in cells
[1, 4]. Therefore, membranes define the cell boundary, they help organize its structures, and
they have multiple communication and regulatory roles in cells.
At first glance, the morphologies of cells are counter-intuitive. Since it is energetically
unfavorable to expose the non-polar hydrocarbon interior of the bilayer to water molecules,
membranes typically assemble to form closed surfaces. As a sphere is the shape which min-
imizes surface area for a given volume, membranes should partition space using this shape.
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Indeed, vesicles are usually spherical. Furthermore, unicellular organisms might be expected
to adopt spherical structure since minimization of surface area means the metabolic cost
associated with producing and maintaining their plasma membrane is also minimized [5].
However, while coccus bacteria are spherical other morphologies such as bacillus ‘rod-shaped’
bacteria and spirillum ‘spiral-shaped’ bacteria are common, and eukaryotic cells display an
even wider variety of membrane morphologies. There are multiple endocytic pathways,
e.g. clathrin-mediated and caveolin-mediated endocytosis, macropinocytosis, phagocytosis,
each of which employ many specialized, dedicated proteins as well as other proteins and
unique lipid compositions in order to deform the membrane into the shapes necessary for
endocytosis [6, 7]. Furthermore, the membrane structures in organelles such as the elab-
orate tubular networks seen in the smooth endoplasmic reticulum [8, 9] and in the inner
mitochondrial membrane [10, 11, 12] exhibit dramatic, complex morphologies and topolo-
gies. By closely regulating their membrane compositions as well as exerting tight control
over their membrane-associated scaffolding cells modify membranes into shapes conducive
to their function.
While cell membrane elasticity has many benefits, it is also a vulnerability. Membrane
curvature in a controlled manner can confer a functional advantage by providing a more
efficient route to take up nutrients and expel waste in the case of endocytosis and exocytosis
[6], or by increasing the membrane surface area per volume to enhance ATP production
in mitochondria [13, 12]. However, excessive membrane curvature or the wrong type of
membrane curvature can be destabilizing. It can lead to unwanted membrane fission events
or uninhibited, direct contact between the cell interior and outside world, both of which
disrupt the barrier function of the cell membrane and jeopardize the life of the cell. Since
the breakdown of membrane integrity has devastating consequences, the susceptibility of cell
membranes to destabilizing curvatures has not gone unnoticed.
The purpose of this thesis is to elucidate the selective mechanisms of action membrane-
active antimicrobial peptides (AMPs) use to destabilize cell membranes [14, 15]. It is well
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known that certain AMPs can multiplex membrane interactions with binding intracellular
targets such as DNA, and some have adopted other specialized roles as modifiers of the host
immune response [14, 15, 16]. However, in the same way that AMPs share a fundamental
structural motif, they are cationic and hydrophobic [14], AMPs share a common ability
to disrupt cell membranes. This thesis provides a detailed molecular model how AMPs
destabilize membranes specifically, based upon their fundamental structural motif. Generic
electrostatic and hydrophobic interactions between a cationic, amphiphilic AMP and a cell
membrane lead to strong binding between the peptide and membrane and subsequent partial
insertion of the peptide into the bilayer. We argue that the physical chemistry of AMPs
leads to a whole taxonomy of local membrane distortions, specific combinations of which
are topologically active and can lead to membrane destabilization. From lyotropic systems,
examples of these curvatures include positive mean curvature seen in micelles, negative
mean curvature seen in inverted hexagonal phases, and negative Gaussian (saddle-splay)
curvature seen in cubic phases. Furthermore, saddle-splay curvature membrane deformations
are expected to be especially disruptive since this type of curvature is topologically necessary
for a number of membrane destabilizing processes.
Chapter 1 reviews the basic properties of lipids and antimicrobial peptides with an em-
phasis on the background information necessary to understand their interactions. Chapter
2 provides a short introduction to small angle x-ray scattering (SAXS), the experimental
method used to characterize AMP-induced membrane curvature, followed by a brief sum-
mary of previous SAXS studies of systems where macromolecule-lipid membrane interac-
tions influenced membrane curvature. Chapter 3 shows that prototypical defensins target
membrane composition differences between host cells and microbes by selectively generating
topologically active saddle-splay membrane curvature only in membranes with compositions
characteristic of bacteria. Moreover, saddle-splay curvature generation places constraints on
the cationic (arginine, lysine) and hydrophobic amino acid contents of AMPs which are con-
sistent with trends in the amino acid compositions of 1,080 known antimicrobial peptides.
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Chapter 4 investigates the correspondence between membrane curvature generation and the
killing activities of α-defensins. We show that the phase behaviors of wild type and variant
α-defensins track with their microbicidal profiles. Therefore, curvature generation is a good
indicator of AMP activity. Chapter 5 presents a systematic study on how the functional
group of arginine, guanidine, generates saddle-splay curvature in homopolymers and poly-
mers enriched with hydrophobicity. We find that curvature generation by poly-guanidine
polymers is sensitive to the spatial arrangement and coordination of the guanidinium groups,
and that hydrophobicity generally enhances saddle-splay curvature generation. Chapter 6,
the outlook chapter, first explores the possibility of other amino acid composition design
rules in AMPs. Next we review other biological systems where the cationic and hydrophobic
structural motif is used to remodel cell membranes. Finally, we highlight our recent research
on a peptide with a different structural motif which generates a different type of membrane
curvature.
1.2 Phospholipid Membranes
1.2.1 Properties of glycerophospholipids, the principle lipids in
cell membranes
The principal structural ingredient in cell membranes is the lipid. In animal cells lipids
constitute about 50% of the total mass of cell membranes [2]. A lipid is an amphipathic
molecule composed of a polar headgroup attached to ‘oily’ hydrocarbon tails. There are
three main types of membrane lipids (1) glycerophospholipids, (2) sphingolipids, and (3)
sterols [4]. Glycerophospholipids are the main lipid type found in eukaryotic cell membranes,
and all of the lipids used in this thesis are glycerophospholipids. The two hydroxyl groups
of their glycerol-3-phosphate backbone (Figure 1.2A) are ester-linked to fatty acid tails
while the phosphate group is ester-linked with a hydrophilic head group such as choline [17].
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The structure of the common glycerophospholipid 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine
(DOPC) is illustrated in Figure 1.1.
Figure 1.1: The typical glycerophospholipid DOPC. Molecular structure (top) and
space-filled model (bottom). Figure adapted from images on Avanti lipids website:
www.avantilipids.com
From a physical standpoint the properties of glycerophospholipids (now referred to as
just lipids) are determined by their head group structures and fatty acid tails. The most
commonly found head groups of cell membrane lipids are shown in Figure 1.2B. Lipids with
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) head groups are zwitterionic,
while phosphatidylglycerol (PG), phosphatidylinositol (PI), phosphatidylserine (PS), and
phosphatidic acid (PA) are anionic with net charge -1 at neutral pH [1]. In addition to
their electrical properties, headgroup size is also important. For example, PC, PG, and PS
headgroups are larger than the smaller PE and PA headgroups [1]. The fatty acid tails
are characterized by the number of carbon atoms, the number of double bonds, and the
structural differences between the two tails. For human erythroctyes typical tail lengths
vary between 16 to 24 carbon atoms with the number of double bonds ranging from 1 to 6
[4].
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Figure 1.2: Glycerophospholipid headgroup structures. A. Glycerol-3-phosphate backbone
B. The most commonly found lipid headgroups of cell membrane lipids. Image from:
http://msr.dom.wustl.edu/Research/Lipidomics.htm
1.2.2 Lipids self-assemble to form membranes
A typical cell membrane is composed of lipids with zwitterionic and charged headgroups
as well as membrane proteins (Figure 1.3). The structure of cell membranes is dictated
by the properties of lipids. The hydrophobic effect drives the aggregation properties of
lipids in water. While van der Waals interactions induce weak attraction between water
and oil, the mutual attraction of water to itself is much greater, which causes segregation of
water from oil [18]. When lipids are placed in water the hydrophobic effect causes them to
self-assemble into a variety of different structures. The one most relevant for cells is their
assembly into membranes composed of lipid bilayers, two sheets of apposing hydrophobic tail
regions sandwiched between the polar headgroups. The basic bilayer structure is found in
both prokaryotic and eukaryotic cells, and despite the great functional diversity of biological
membranes, most are composed of a lipid bilayer [1]. This structure was first inferred
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through Langmuir trough studies [19], and later directly observed by TEM studies [20] on
cell membranes. More recently, x-ray and neutron diffraction experiments have determined
the time-averaged transmembrane probability distribution curves of lipid components (e.g.
phosphates, methylenes) for a lipid bilayer in a fluid state [21, 22]. While these results reveal
there is significant out of membrane thermal motion based on the widths of the probability
densities, the densities are consistent with the bilayer structure.
Figure 1.3: Illustration of a cell membrane. Illustration is from Wikimedia commons and
was originally made by Dana Burns. Also found in [23]
Physically the cell membrane bilayer is a two-dimensional smectic A liquid crystal alloy
composed of lipids and integrated proteins. This is often restated in the textbook Singer-
Nicholson fluid mosaic model [24] where the bilayer has long range order but lacks short
range crystalline order. Support for viewing the bilayer as a two dimensional lipid solvent
containing soluble proteins comes from measurements of lateral movement of membrane con-
stituents. Although lateral diffusion rates of phospholipid molecules vary depending on their
properties and the specific composition of the membrane, typical lateral diffusion coefficients
are measured to be 10−8 10−7cm2/sec in fluid membranes [25, 26]. This indicates that for
a bacterium such as E. Coli, a lipid can explore the entire plasma membrane surface area
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in about a second. Similar measurements on integral membrane proteins reveal that many
have comparable diffusion rates [27, 28]. However, these proteins appear to be exceptions to
the norm. Most membrane proteins do not experience unrestricted lateral diffusion which is
expected for a random two dimensional fluid [29]. At the simplest level this indicates there
is some amount of lateral heterogeneity in membrane structure. Indeed, emerging evidence
suggests the presence of microdomains - membrane regions enriched in certain types of pro-
teins and lipids due to their preferential association with one another [30]. One example is
the so-called lipid raft hypothesis, which supposes the existence of distinct domains consist-
ing of cholesterol, sphingolipids, saturated lipids, and a variety of proteins, especially those
involved in cell signalling [31, 32, 33]. Furthermore, interactions between the membrane and
cell cytoskeleton often modify the lateral movements of membrane proteins and alter the dis-
tribution of both proteins and lipids in the membrane [29, 30]. Taken together these results
indicate that cell membranes are not simply 2D random distributions of lipids and proteins.
Instead interactions between membrane molecules as well as between these molecules and
their surroundings impose a degree of lateral organization in cell membrane structure.
1.2.3 Structural properties of lipids influence the physical
properties of the membrane
The fluidity of a cell membrane will depend on its composition. A cell membrane is a
highly diverse composite of many different varieties of lipids and proteins. For example,
erythrocytes contain over 100 different lipid types [4]. To simplify matters biophysicists
typically study the phase behavior of membranes composed of a single lipid species as a
function of temperature or water content (Figure 1.4A). For phosphatidylcholine (PC) lipids
the typical phase progression with increasing temperature is gel (Lβ′), rippled gel (Pβ′), and
finally liquid (Lα) phase [34]. Gel phases are characterized by their lipid hydrocarbon chains
being essentially ordered and ‘frozen’ in the all-trans conformation, while in liquid phases
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Figure 1.4: The different lamellar phases. A. Illustration of liquid disordered phase (top
left), ripple phase (top right), gel phase (bottom left) and liquid ordered phase (bottom
right). B. The gel-liquid phase transition at the melting temperature, Tm. Image is adapted
from [34].
the chains have melted into a disordered fluid state. In the (Lβ′) phase the hydrocarbon tails
are organized in a crystal lattice structure, and are tilted in respect to the direction normal
to the plane of the membrane. Since the Lβ′ → Pβ′ transition is a solid-solid transition the
hydrocarbon chains remain ordered. The Pβ′ also has crystallized hydrocarbon tails that
are tilted, but with the additional remarkable feature of a rippled structure. Finally at the
chain melting temperature, Tm, the chains transition from the all-trans to a disordered state
and the liquid disordered Lα phase appears [34]. However, these phases are not exhaustive,
especially in multicomponent membranes. For example, a liquid ordered, Lo, phase where the
lipid chains are in a liquid but ordered state has been proposed for membrane microdomains
such as lipid rafts which are enriched in cholesterol and phospholipids with saturated tails
[31].
The gel to liquid melting temperature, Tm, is an important lipid property, since biological
membranes must be in a liquid state for proper cell function (Figure 1.4B). In general, Tm
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increases with chain length, and introduction of a non-saturated bond into hydrocarbon
chains will tend to drastically reduce Tm [34]. For example, 18:1c9 PC (DOPC), meaning
one double bond at the 9th carbon of the 18 carbon tails in cis- state, has Tm = −20◦C,
saturated 16:0 PC (DPPC) has Tm = 40
◦C, and 16:1 PC has Tm − 36◦C. Tm is also highly
dependent on lipid headgroup [35]. In PE lipids 18:1c9 PE (DOPE) has Tm = −16◦C,
while the commonly used 16:0-18:1 PE (POPE) lipid has Tm = 25
◦C, right around room
temperature [35]. This should be kept in mind when using POPE lipids.
1.2.4 Interactions between lipid molecules can generate
membrane curvature
Liquid phases such as the Lα are the most relevant to the structure and function of biomem-
branes. Above Tm, lipid molecules will tend to self-assemble into the liquid lamellar phase
- locally flat membranes of the basic bilayer structure. However, this is not always the
case. Asymmetry between the monolayer leaflets composing the bilayer from differences in
lipid and protein composition, or in solution conditions across the bilayer can influence the
membrane and cause it to bend away from a flat state. Even in symmetric bilayers certain
compositions and conditions can render the membrane more susceptible to being curved. If
a perturbation tends to promote membrane curvature towards the aqueous solution, then
transitions from the lamellar phase to non-lamellar cubic or inverted hexagonal phases be-
come more favorable. Recently much research has focused on non-lamellar phases. A large
amount of electron microscopy data supports the existence of both hexagonal and cubic
phases in certain cell types [36]. Lipid membranes and genetic material such as DNA and
RNA self-assemble into inverted hexagonal [37, 38] and cubic [39] complexes which have
potential biotechnological applications for drug delivery and gene therapy. And lipidic cubic
phases have been used to crystallize membrane proteins [40].
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1.2.5 Formalisms of membrane curvature
Membrane curvature can be described using formalisms from topology. At any point on a
membrane the surface will curve in a manner that depends on direction. For smooth surfaces
the membrane will bend maximally in one direction and minimally in the perpendicular
direction (Figure 1.5). These extremum directions of curvature are called the principal
directions. By constructing circles with radii, Rmax and Rmin, which best fit the curvature
along the principal directions the principal curvatures, c1 = 1/Rmax and c2 = 1/Rmin, are
defined at any point. The principle curvatures can be combined into two different general
expressions to describe the shape of the surface:
H =
1
2
(c1 + c2) (1.1)
K = c1c2 (1.2)
H is the average or mean curvature, while K is the Gaussian curvature. Flat lamellar
surfaces have both zero mean curvature and zero Gaussian curvature. If the surface is
rolled up into a cylindrical object the mean curvature will be non-zero, while the Gaussian
curvature will remain zero. Objects such as spheres have both non-zero mean curvature and
positive Gaussian curvature, since c1 and c2 have the same sign. If c1 and c2 are opposite
sign the surface has negative Gaussian curvature (also called saddle-splay curvature), and
locally will have the shape of a saddle. A surface with c1 = −c2 at every point is known as
a minimal surface. In accordance with convention this thesis defines negative curvature as
when a membrane monolayer bends away from the non-polar interior and toward solution,
and positive curvature when the monolayer bends in the opposite way. For example, with
this definition inverted hexagonal phases have negative mean curvature.
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Figure 1.5: At any point, P, on a surface the principle axes of curvature, c1 = 1/Rmax and
c2 = 1/Rmin, describe the curvature at that point. Image adapted from [41].
1.2.6 Geometrical packing model of lipid molecules
Equipped with a topological description of surface curvature, the contribution of lipid
molecules to membrane curvature can be discussed. One commonly used approach to un-
derstand lipid polymorphism is the “geometric packing” model developed by Israelachvili
et al [42]. In this model the concept of an average molecular shape for a lipid molecule
is introduced. Aggregated lipids experience two very different environments. In their hy-
drophobic interior region their tails interact mainly through attractive van der Waals and
repulsive steric forces. Differently, in the hydrophilic headgroup region repulsive steric in-
teractions, electrostatically-based interactions including those directly between ionic and
zwitterionic lipid headgroups, and with head groups and aqueous phase ions, counterions,
and water molecules, all contribute [42]. The directions and strengths of these forces acting
throughout the lipid are subsumed into an average molecular shape which is described with
a dimensionless packing parameter, S, where
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Figure 1.6: Illustration showing the relationship between the packing parameter, the geo-
metric representation of the lipid, and the preferred aggregate. Adapted from [43].
S =
V
A0Lc
(1.3)
Here V is the molecular volume of the hydrocarbon tails, A0 is the optimal head group
area, and Lc is the critical chain length. Israelachvili showed that lipids tended to assemble
into aggregates with a geometry consistent with their packing paramters. For example,
the single-chained lipid, lysophosphatidylcholine has 1/3 < S < 1/2 and tends to form
positively curved micellar structures [43]. The various packing parameter values and their
corresponding lipid shapes are summarized in Figure 1.6.
Representing the forces experienced by an aggregated lipid as an average molecular shape
is useful for understanding polymorphic phase behavior of lipids. Qualitative agreement is
seen between the geometric packing model and certain experiments. It does have limitations,
however. For example, this model cannot predict the formation of bicontinuous cubic phases,
such as those found in single component membranes composed of monoolein [44]. Since cubic
phases have negative Gaussian curvature the average shape of the constituent lipid molecules
will be splayed in one direction and compressed in another so they cannot be described by
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a single packing parameter. Furthermore, generalizing this model to multi-component lipid
membranes is not straightforward, and the model cannot explain the rich phase behavior
observed in these systems [45, 46]. Finally, an important property of membranes is how they
respond to being deformed away from their native state. In the molecular packing picture
deforming a aggregate of lipids can be visualised as producing gaps and overlapping regions
between the lipid ‘building blocks’. It is therefore apparent that such deformations should
be energetically penalized. However, in order to translate this into a membrane curvature
elasticity component to the system free energy an alternative approach first proposed by
Helfrich is generally used.
1.2.7 The Helfrich approach
In this approach the curvature elastic energy per unit area of bending a membrane monolayer
from its native state is [47]:
Fc = 2κ(H − c0)2 + κGK (1.4)
Here c0 is the spontaneous curvature. The bending modulus, κ, is a constant that
describes the stiffness of the membrane, while the Gaussian curvature modulus, κG, is a
constant related to how amenable the membrane is to Gaussian curvature deformations.
The first term in the equation measures the energetic penalty of bending the membrane
away from its spontaneous curvature, while the second term measures the energetic penalty
of Gaussian curvature distortions which bend and stretch the membrane and are prerequisite
to topological transitions.
The monolayer spontaneous curvature arises because the interactions in the monolayer
will depend on the position in the monolayer. For example, at the hydrophilic surface the
interactions between the lipid headgroups will generally produce different in-plane forces
than the interactions between the lipid tails at the hydrophobic surface. If the sum of the
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in-plane forces is balanced for an area which is smaller at the headgroups than at the tail
ends, then the minimum-energy configuration is a monolayer which bends back toward the
headgroups. In this situation the monolayer is said to have negative spontaneous curvature,
i.e. c0 < 0. Lipids which tend to promote this configuration are called negative spontaneous
curvature lipids. They are typically illustrated with small headgroups and splayed tails,
or geometrically as having a traffic cone shape. At physiological conditions the physical
and chemical properties of PE and CL often render them negative spontaneous curvature
lipids. Differently, the properties of PC and PG lipids typically lead to in-plane forces
at their headgroup and tail regions which are balanced for equivalent areas. These lipids
typically self-assemble to form flat membranes, i.e. c0 ≈ 0, and they are often geometrically
represented as having cylindrical shape.
Another way to understand this is by examining the lateral stress, t(z), as a function
of the distance, z, through a lipid monolayer. A typical lateral stress profile is depicted in
Figure 1.7A. At the interface the hydrophobic effect acts to minimize the amount of contact
between the surrounding water molecules and hydrocarbon tails. This produces an interfacial
pressure which pushes the lipid molecules together in the bilayer. Offsetting the attraction
are repulsive pressures due to steric interactions between the hydrocarbon chains and the
steric, electrostatic, and hydration interactions between headgroups. The equilibrium area
per lipid throughout the monolayer is achieved when the integral of the lateral stress across
the lipid monolayer,
∫
t(z) dz, is zero. Since the first moment of the lateral stress profile,∫
zt(z) dz, is proportional to c0, lipid lateral stress profiles from inter-lipid interactions affect
monolayer curvature [48].
It should be noted that if two monolayers with identical spontaneous curvatures combine
to produce a membrane bilayer the spontaneous curvature of the bilayer must be zero to avoid
producing energetically costly voids (Figure 1.7B). Bilayer spontaneous curvature arises from
asymmetry between the monolayer leaflets. However, the consequences of forming a lamellar
phase membrane with c0 6= 0 monolayer leaflets is stored elastic energy. As we shall see, for
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Figure 1.7: Lipid lateral stress, t(z), profiles affect membrane curvature. A. Schematic
of the lateral stress through a lipid monolayer. At equilibrium the integral of the lateral
stress is zero. The first and second moments of the lateral stress are equal to −κc0 and
κG, respectively [49]. Therefore, t(z) determines the curvature properties of a monolayer.
B. Joining monolayers with non-zero spontaneous curvature produces a bilayer with zero
curvature provided there is no asymmetry between monolayers. Adapted from [41].
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antimicrobial peptides the presence of greater amounts of negative spontaneous curvature
lipids in bacterial membranes compared with eukaryotic membranes is important for their
selective activity.
1.2.8 Relationship between monolayer and bilayer curvature
elastic parameters, and their influence on topological
transitions
For a symmetric bilayer the bilayer spontaneous curvature, cb0, bending modulus, κ
b, and
Gaussian modulus, κbG, are related to the monolayer elastic parameters through the following
expressions [50]:
cb0 = 0 (1.5a)
κb = 2κ (1.5b)
κbG = 2(κG − 4κc0d) (1.5c)
The first expression simply restates that the membrane is symmetric. The expression for
κb explains that the energy required to bend two monolayers is twice the amount needed to
bend one. The third expression is more complicated, as κbG is not simply twice the monolayer
Gaussian modulus, but it also depends on κ, c0, and d, the distance from the middle of the
bilayer to the monolayer pivot point. The bilayer Gaussian curvature modulus is related
to the resistance of the membrane to topological transitions. This is a consequence of the
Gauss-Bonnet theorem, which can be used to show that the integral of Gaussian curvature
over a closed surface with genus, g, is [50]
∫
K dA = 4pi(1− g) (1.6)
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The genus is zero, g = 0, for a sphere. For a torus, g = 1, which is topologically equivalent
to a sphere with a ‘handle’. For each new handle the genus increases by one. As expected,
spheres have K = 4pi, total Gaussian curvature, while torus has K = 0, and so on with the
formation of each handle imparting a change of −4pi Gaussian curvature. Infinite periodic
minimal surfaces such as the Pn3m (D), Im3m (P), and Ia3d (G) cubic phases (Figure 1.8)
have infinite genus and are therefore rich in negative Gaussian curvature. A simple way to
understand the connection between κbG and topological transitions is to examine the lamellar
to cubic phase transition. As stated before lamellar phases have H = 0, and K = 0, whereas
cubic phases have H = 0, while K < 0. Therefore the difference in curvature energy between
the two phases, ∆F , comes solely from their differing Gaussian curvatures [50]:
∆Fc = Fcubic − Flamellar = κbG
∮
K dA = κbG〈K〉A (1.7)
where 〈K〉 (< 0) is the average negative Gaussian curvature over the membrane area, A.
So cubic phase formation is energetically favorable when κbG > 0. Similarly, the formation
of a toroidal pore in an intact lamellar membrane, produces ∆K = −4pi change in Gaussian
curvature, with a ∆E = −4piκbG energy change from the Gaussian curvature contribution to
the curvature energy [51]. (Since there is no guarantee that the toroidal pore interior will be
a minimal surface, the mean curvature contribution to the energy must also be taken into
account in order to get the full ∆Fc). However, the point is membranes with positive κ
b
G
will produce porous phases, and those with barely negative κbG will be more vulnerable to
∆K < 0 topological transitions. An interesting consequence of κbG ∝ −c0 is that membranes
enriched in c0 < 0 lipids should be more susceptible to pore formation.
1.2.9 Basic properties of cubic phases
Much of the work in this thesis is centered around bicontinuous cubic phases (QII) (Fig 1.8)
and their underlying negative Gaussian surface curvature. Therefore, a brief description of
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Figure 1.8: The three most commonly observed bicontinuous cubic phases in lyotropic sys-
tems. The Pn3m ‘double-diamond’ phase (left), the Im3m ‘plumber’s nightmare’ phase (mid-
dle), and the Ia3d ‘gyroid’ phase (right) Images rendered using Matlab m-files created by
the Gruner lab: bigbro.biophys.cornell.edu/~toombes/Software/Minimal_Surfaces/
them is necessary. QII phases display three dimensional periodicity, where their minimal
surface divides space into two inter-linked but not intersecting regions. Physically, a lipidic
cubic phase can be visualised where the membrane bilayer is ‘draped’ over the minimal
surface, such that the lipid head groups remain hydrated by the two water channels. The
center of the bilayer, where the hydrocarbon tail ends meet, traces the minimal surface.
While H = 0 along the minimal surface, this is not true for surfaces parallel to the
minimal surface within the bilayer. For example, moving a distance ξ from the mid-bilayer
minimal surface to a parallel surface, changes the principal curvatures from, c1 = −c2 = 1/R,
to cξ1 = 1/(R + ξ) and c
ξ
2 = −1/(R − ξ) on the parallel surface. The relations for surfaces
parallel to the minimal surface are [41]
Hξ =
Kξ
1 +Kξ2
(1.8a)
Kξ =
K
1 +Kξ2
(1.8b)
dAξ = dA[1 +Kξ2] (1.8c)
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where dA is the area element of the surface. Since cubic phases have K < 0, the relations
show that on the parallel surface both Hξ and Kξ are more negative than on the minimal
surface. In fact while H = 0 on the minimal surface, on any parallel surface Hξ < 0.
Therefore, just like inverted hexagonal phases which have H < 0, cubic phases with Hξ ≤ 0
are often referred to as inverted phases.
So far no distinctions have been made between different bicontinuous cubic phases. While
many cubic minimal surfaces exist [52] only the D, P, and G phases have been experimentally
observed in lyotropic systems. By modelling the distribution of Gaussian curvature over 7
different bicontinuous cubic phases, Schwarz and Gompper [53] showed that the D, P, and G
cubics have smaller widths in their Gaussian curvature distributions. Therefore, these three
cubic phases experience smaller frustration which leads to their enhanced stability. With
respect to their relationship with each other the D, P, and G phases are related by a Bonnet
transformation, a one-to-one surface mapping which preserves the distribution of Gaussian
curvature at all points on the surface [54]. Two consequences of the Bonnet transformation
are: For the correctly chosen ratio of lattice parameters the three minimal surfaces will have
same area per unit cell, and their curvature energy will be degenerate. The average Gaussian
curvature, 〈K〉, for a minimal surface with Euler characteristic, χ, and surface area of a unit
cell with sides of length 1, A0, is [55]
〈K〉 =
∫
unitcell
K dA∫
unitcell
dA
=
2piχ
a2A0
(1.9)
where a is the lattice parameter of the cubic phase. The parameters for the three phases
are shown in Figure 1.9. By equating 〈K〉 for the D, P, and G surfaces we find: aP/aD = 1.279
and aG/aD = 1.578 [55]. Coexisting cubic phases with lattice parameters at these ‘Bonnet
ratios’ are often observed in lipid-water systems [41]. Comparison of the D, P, and G lattice
parameters at Bonnet ratios reveals that for a given average Gaussian curvature, 〈K〉, the
Pn3m has the smallest lattice parameter followed by the Im3m and then the Ia3d. Lastly,
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Figure 1.9: Characteristics of the ‘genus-3’ bicontinuous cubic phases
the morphologies of the three cubics differ in their porosity, or the number of water channels
that split off at each junction. The Im3m ‘plumber’s nightmare’ is the most porous with
six vertices, while the Pn3m ‘double-diamond’ and Ia3d ‘gyroid’ phases have four and three
vertices, respectively.
1.3 Wet Electrostatics
Almost all biomembranes display electric charge. The anionic lipid phosphatidylserine ac-
counts for 10-20% of the lipid content in erythrocyte plasma membranes [56]. Bacteria cell
membranes typically contain more negatively charged lipids. And in some cases, for ex-
ample, Staphylococcus aureus whose cell membrane contains roughly a 50/50 mixture of
phosphatidylglycerol and cardiolipin, essentially the entire membrane is composed of lipids
with electronegative headgroups [57, 58]. Furthermore, biomembranes often contain other
polyanionic molecules which affect their surface charge, such as heparin sulfate cell surface
receptors [59, 60] in eukaryotic cells and lipopolysaccarides and lipoteichoic acids which
decorate the surfaces of Gram-negative and Gram-positive bacteria [16], respectively. The
presence of electric charge affects many of the physical characteristics of membranes. Struc-
tural properties including membrane rigidity, phase transition temperatures, and dynamics
depend on membrane charge density [61]. Furthermore, membrane charge plays an impor-
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tant role in the interactions between biomembranes and other molecules. This thesis is
primarily concerned with peptide-membrane interactions. The purpose of this section is to
provide a brief overview of the field of wet electrostatics and discuss its concepts within the
context of anionic cell membranes and cationic antimicrobial peptides. The treatment below
has been adapted from discussions of the Poisson-Boltzmann equation and Debye-Hu¨ckel
theory in references [3, 62, 61].
When a macromolecule is dissolved in solution it often releases ions into the suspension
and becomes charged. The charged regions on the macromolecule will attract oppositely
charged counterions in the suspension, which localize around the charged macromolecule.
The resulting ‘cloud’ of counterions forms a electrical double layer, perturbing or ‘screen-
ing’ the electrostatic potential of the macromolecule. At physiological conditions the large
dielectric constant of water along with the electrical double layer of ions and dissociated
salts strongly screen electric fields produced by macromolecules like AMPs and assemblies
like lipid membranes. It is this electrical double layer that influences how a macromolecule
interacts with its environment. Therefore, understanding the basic structure and properties
of the double layer is important.
1.3.1 The Poisson-Boltzmann equation & Debye-Hu¨ckel theory,
part I
Consider a charged flat surface (placed at x = 0) with negative surface charge density −σ,
that is hydrated by an ionic solution with dielectric constant  in the x > 0 region. At any
point in the solution the (mean field) electrostatic potential, ψ(z), is related to the charge
distribution, ρ(z), through the Poisson equation
∇2ψ = ρ

(1.10)
For simplicity we assume there are only two types of mobile charges in the solution,
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counterions and co-ions. The charge density is therefore: ρ = ez+n+ + ez−n−, where n+
(n−) are the number densities of the counterions (co-ions) and z+ (z−) are their valences.
Within the mean field approximation the electrostatic potential energy of a counterion at
position x is eψ(x). Since this allows the ions to be treated as acting independently of each
other, the density of the ith ion is given by the Boltzmann distribution
ni = n
i
0e
−eψ(x)
kbT (1.11)
where e is the electric charge, kB is the Boltzmann constant, T is the temperature, and
ni0 is a constant. To get a general idea of the size of the double layer we first assume the
surface is submerged in pure water. With no additional electrolyte the only ions present are
counterions, so n− = 0, and we define n+ ≡ n, and n+0 ≡ n0 as a reference density where
ψ = 0. To simplify matters we define a dimensionless rescaled potential ψ¯(x) ≡ eψ(x)/kBT .
Combining expressions (1.10) and (1.11) gives the Poisson-Boltzmann equation
d2ψ¯
dx2
= −4pilBn0e−ψ¯ (1.12)
where
lB ≡ e
2
4pikBT
(1.13)
is the Bjerrum length in water. The Bjerrum length is the distance between two like-
charge ions where their electrostatic interaction energy equals the thermal energy kBT . For
monovalent ions in water at room temperature, lB = 0.71nm. Generally speaking, Poisson-
Boltzmann theory is a good approximation for most physiological conditions, especially in
systems that contain mostly monovalent ions and surfaces with charge densities that are not
too large.
The Poisson-Boltzmann equation is a non-linear differential equation. Typically closed
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form solutions of these equations are not known, and the standard procedure is to either
linearize them to get an approximate solution, or to solve them numerically. However,
the geometry of an infinite flat surface renders this problem tractable. To solve a second-
order differential equation with unspecified n0 requires three boundary conditions. Setting
ψ(0) = 0 turns n0 into the concentration of counterions at the surface. Since the electric
field should approach zero at distances far from the surface, dψ/dx→ 0 out there. Finally,
the surface form of the Gauss law gives
dψ¯
dx
∣∣∣
surface
= 4pilB
σ
e
(1.14)
Applying these conditions and integrating the Poisson-Boltzmann gives the potential,
ψ(x), in the aqueous solution (x > 0), and n(x) is obtained from ψ(x) via the Poisson
equation. They are
ψ(x) = 2
kBT
e
ln(1 + x/b) (1.15a)
n(x) =
1
2pilB
1
(x+ b)2
(1.15b)
where b = (2pilBσ/e)
−1 (1.15c)
The variable, b, is the Gouy-Chapman length, and it is a rough measure of the thickness
of the double layer of counterions that forms around the charged sheet. Rewriting the
Gouy-Chapman length as b = ( 2
eσ
)kBT allows us to see another interesting interpretation.
An isolated counterion next to the charged surface, which has electic field −σ/2, can be
displaced a distance b by doing kBT amount of work. In other words the counterions ‘borrow’
some thermal energy from their environment in order to move approximately a distance b
away from the surface. This occurs because the entropic gain is greater than the electrostatic
penalty, which leads to a overall reduction of their free energy.
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Another way to think about this kBT energy per counterion is to picture the double
layer as a planar sheet of charge held at a distance b from the surface. In this model we
have a parallel plate capacitor which stores electrostatic energy E = Q2tot/2C, where over
an area A on the capacitor Qtot = σA. The capacitance, C, of a parallel plate capacitor
is C = A/b. Combining the previous three equations gives an estimate of the amount of
stored electrostatic energy per unit area for a charged surface in water: E ≈ kBT (σ/e).
Again a counterion borrows around kBT energy from the environment. Recall that the cell
membrane of Staphylococcus aureus is entirely composed of anionic lipids. This bacterium
is roughly circular with a diameter of 1µm. We approximate the area of a lipid as 0.7nm2
so |σ/e| = 0.7nm−2. When submerged in water Staphylococcus aureus carries a stored free
energy of ≈ 4pi(0.5µm)2 × (0.7/nm2)kBT ≈ 2e6kBT in its plasma membrane.
1.3.2 The Poisson-Boltzmann equation & Debye-Hu¨ckel theory,
part II
The purpose of the last subsection was to illustrate two ideas: Screening reduces the range of
electrostatic interactions to roughly the Gouy-Chapman length, but this does not mean that
electrostatic interactions are weak. However, the above results were for a charged surface
submerged in pure water. Cells live in electrolyte solutions, so in biological conditions the
bulk concentrations of both counterions and co-ions are non-zero. How does the presence of
salt matter? Approximating the bulk electrolyte as a reservoir of monovalent ions such as
NaCl the Poisson-Boltzmann equation becomes:
∇2ψ¯ = λ−2D sinh(ψ¯) (1.16)
Here λD, or the Debye screening length, is defined as
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λD ≡ (
∑
i
4pilBzin
∞
i )
−1/2 (1.17a)
λD = (8pilBn
∞)−1/2 For 1:1 salt like NaCl (1.17b)
where n∞i is the bulk concentration of the ith ion. Under physiological solution conditions
typical Debye lengths are less than a nanometer. For example for a 1:1 electrolyte such as
NaCl at 100mM the screening length is 9.6 A˚.
The added salt Poisson-Boltzmann equation also can be solved in closed form. Using the
same surface boundary condition (1.14), in addition to ψ(x) → 0, & dψ
dx
→ 0 as x → ∞ it
can be shown that the resulting potential is
ψ(x) = −2kBT
e
ln
1 + γe−x/λD
1− γe−x/λD (1.18)
where
γ =
b
λD
(
√
1 + (λD/b)2 − 1) (1.19)
The surface potential ψs = ψ(0) is
ψs = −4kBT
e
arctanh(γ) (1.20)
Therefore, while the surface potential was determined entirely by its charge density for a
surface immersed in water, the potential of a surface in electrolyte is also affected by the bulk
salt concentration. In the limit of high salt concentration (small λD) the surface potential
becomes very small, and the electrostatic potential can be approximated as
ψ(x) = ψse
−x/λD = −σλD

e−x/λD (1.21)
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Under high salt the electrostatic properties of the surface are strongly screened and
decay exponentially. The double layer of ions surrounding the surface is characterized by
a thickness λD, typically around a nanometer at physiological solution conditions. Unlike
the double layer in the no-salt case which had constant thickness, b, adding salt shrinks the
Debye screening length. Therefore, increasing the concentration of salt decreases the size of
the double layer. Furthermore, in the no-salt case as the surface charge density is reduced
the Gouy-Chapman layer, b, grows without limit. This does not happen under the presence
of added salt, it can only grow until it reaches the Debye screening length [63].
Why does the size of the double layer decrease when salt is added to the solution?
Referring back to the original argument about the competition between electrostatic energy
and entropy, a smaller double layer implies that counterions have less to gain entropically
by distancing themselves from the surface. This makes sense because there is a non-zero
concentration of counterions everywhere in solution.
Lastly is the short ranged behavior of electrostatic interactions something specific to
surfaces? For charged surfaces we found that their counterions remained confined around the
surface even upon infinite dilution (pure water solution). This phenomena is often referred
to as counterion condensation. The counterions remain condensed within a Gouy-Chapman
length of the surface. While lipid membranes are usually a (locally) flat 2D surface, many
other biological macromolecules have different geometries. For example, the persistence
length of double-stranded DNA is about 50nm, and cytoskeletal filaments like F-actin and
microtubules have persistence lengths on the order of microns. The counterion condensation
of 1D rod-like polyelectrolytes is more peculiar. Consider an isolated counterion (valence
e) in the proximity of an infinite rod with radius a, and charge density ν. Approximating
the polyelectrolyte as a stiff rod composed on ionized monomers of charge e, and spacing
d, we write ν = e/d. Releasing the counterion to a distance r away from the rod costs
e2
2pid
ln(r/a) electrostatic energy, while the entropic gain is kBT ln(
pir2
pia2
) [64]. Comparing
electrostatic and entropic components of the free energy, we find that the charge density of
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the rod determines the condensation behavior of the counterions, according to the value of
the Manning parameter, ξ [64]
ξ ≡ e2
4pikBT
1
d
=
lB
d
(1.22)
If ξ < 1 the counterions are released and fully dissociate into solution. However, for
highly charged electrolytes Manning showed that the partition function for a ‘condensed’
ion diverges if ξ > 1. This implies that counterions must condense onto the rod until
its surface charge density is renormalized to the point where the average spacing between
charges, d equals the Bjerrum length, lB. For example, DNA carries a large amount of
negative charge. Since it has 20 phosphate groups per helical pitch of 3.41 nm, 76% of
the anionic groups of DNA are neutralized by Manning condensation [65]. Moving down in
dimension to ‘point-like’ molecules, as a consequence of their ψ ∝ 1/r electric potential it
can be shown that upon infinite dilution all counterions are released. However, adding salt
to the solution changes the entropic landscape. And in the presence of bulk electrolyte a
charged macromolecule remains surrounded by an λD electric double layer of counterions
according to Debye-Hu¨ckel theory [63].
In summary, electrostatic forces are short ranged due to the clustering of mobile ions
which act to screen electrostatic fields to the range of around a nanometer. However, clus-
tering ions reduces their accessible volume. Therefore, compared to the ‘free ion’ config-
uration, the electrical double layer configuration has reduced entropy. And built into the
reduced entropy of ion configurations around charged macromolecules is the potential for
strong inter-macromolecular interactions. In the case of antimicrobial peptide-lipid mem-
brane interactions, overlap of the electronic double layers of a cationic AMP and an anionic
membrane allows their opposite charge distributions to replace condensed counterions. The
counterions are released from their bound state and into solution for a large entropic gain,
which generates a strong attraction between the polymer and membrane.
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1.4 Antimicrobial Peptides
The emergence of bacterial resistance to current antibiotic strategies is a global health prob-
lem. For example, methicillin-resistant [66] Staphylococcus aureus (MRSA) and Staphylo-
coccus aureus with complete resistance to vancomycin [67], often referred to as the drug of
last resort, first appeared in U.S. hospitals in 2002. A report by the WHO in 2008 showed
that the number of cases of extensively drug resistant Mycobacterium tuberculosis [68] had
reached the highest levels ever recorded. Rational treatment approaches such as improve-
ments in the use of antimicrobials and precautions to reduce the transmission of resistant
bacterial strains help slow the rate of emerging resistance. The use of antibiotics itself, how-
ever, exerts a strong selective pressure in favor of drug-resistant bacteria. Whats worse, the
pharmacological development of antimicrobials tends to be expensive and slow, and present
methods are not well adapted to the challenge of rapidly evolving bacterial resistance. There-
fore, there is a significant need to have design rules that rationally guide the synthesis of
new antimicrobials by reducing the large parameter space of molecular compositions.
Cationic antimicrobial peptides (AMP) are present in virtually every multi-cellular or-
ganism, and comprise an important part of the innate host defense [14, 15, 69, 70, 16, 71].
Collectively, AMPs display broad spectrum antimicrobial activity and have a rapid mecha-
nism of action [14, 15, 16]. Despite being one of the oldest components of the host immune
system, bacteria have not been able to evolve resistance and AMPs remain effective antimi-
crobial agents [14, 16]. Here we review the field of antimicrobial peptides, primarily, within
the context of peptide-membrane interactions.
1.4.1 Structural features of natural and synthetic AMPs
To date over 1000 AMPs have been discovered. Despite the enormous structural diversity of
AMPs most share a few broad structural features. AMPs are short (< 50 amino acids), have
net positive charge (+2 to +9), and contain a significant proportion of hydrophobic amino
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acids (> 30%) [14, 15, 69, 70, 16, 71]. Generally their cationic and hydrophobic residues
spatially partition into discrete clusters to form an amphipathic secondary structure (Figure
1.11). AMPs are often classified by these folded structures (Figure 1.10). One subgroup
consists of linear peptides such as magainins [72] from frogs, and LL-37 cathelicidins [73]
from humans. These peptides adopt alpha helical structures when they partition into a
membrane interface which segregates their polar and hydrophobic residues on opposite faces
of the helix (Figure 1.10A). Another subgroup of AMPs includes peptides that consist of beta
sheet structures stabilized by disulfide bonds from cysteine residues, such as protegrins [74]
from pig, and defensins [75, 76, 77] (Figure 1.10B-D). Mammalian defensins include alpha
defensins such as cryptdins [78] from mouse, beta defensins like the human beta defensins
[76] and theta defensins [79] which are found only in old world monkeys (Figure 1.10B&C).
A third subgroup is categorized by extended linear peptides with sequences dominated by
a few amino acids, like the tryptophan-rich indolicidin [80] from cattle, and the arginine
and proline-rich PR-39 [81] from pig (Figure 1.10E). Lastly there are peptides derived from
proteolysis of proteins such as buforin II [82] from histone 2A which is expressed in frog, and
lactoferricin B [83] from gastric pepsin digestion of bovine lactoferrin.
Based on the central hypothesis that the activity of many AMPs may depend more on
their fundamental cationic and amphipathic properties (Figure 1.11) than on their precise
amino acid sequences and secondary structures, a variety of synthetic antimicrobials have
been designed using different chemistries. One method is to modify existing AMP sequences
to maximize antimicrobial activity while also minimizing hemolytic activity to optimize ther-
apeutic potential. Examples of synthetic AMPs which have been developed by modifying
natural versions include MS-78 (pexiganan) [85], a variant of the AMP magainin from frogs,
iseganan [86], a variant of protegrin from pigs, and omiganan [87], a cattle indolicidin variant.
By using the positively charged amphipathic features as templates, synthetic AMP analogues
have been constructed. These analogues include model antimicrobials based upon mimicking
the peptide primary structure (peptidomimetics), and ones that use non-peptidic compounds
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Figure 1.10: Common secondary structures of antimicrobial peptides. A. α-helical magainin-
2 from frog. β-sheet AMPs: B. human β-defensin-2, C. rabbit kidney α-defensin-1 and D.
polyphemusin from Japanese horseshoe crab. E. Linear bovine indolicidin. Disulfide bonds
are colored yellow. Molecules were prepared with graphic program MolMol 2K.1. Adapted
from ref [84]
.
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[88, 89]. Peptidomimetic antimicrobials have been made using β-peptides [90, 91, 92] and
peptoids [93]. These peptides folded into amphipathic structures and demonstrated potent in
vitro anti-bacterial activity. Furthermore, unlike the α-peptide backbone of natural AMPs,
both β-peptides and peptoids offer the additional advantage of being resistant to proteases.
Non-peptidic compounds include facially amphipathic acrylamide polymers [94], phenylene
ethynylene molecules [95], polymethacrylate derivatives [96], and polynorborene derivatives
[97], which all displayed potent selective activity against Gram-positive and Gram-negative
bacteria. Since these synthetic antimicrobials are also cationic and amphipathic, it is believed
their mechanism of activity is similar to AMPs. Interestingly, random copolymers composed
of amphiphilic polymethacrylate derivatives showed activity comparable to natural antimi-
crobials with low hemolytic activity [96]. And disulfide null analogues of α-defensin Crp4 [98]
and human β-defensin-3 [99] showed in vitro bactericidal activities equal to or greater than
the wild type peptides. Since removal of the tridisulfide array rendered Crp4 extensively sus-
ceptible to proteolysis, it was concluded that the purpose of disulfide arrangement in Crp4 is
not to confer bactericidal activity but to offer protection against degradation [98, 100]. These
last results suggest that prearranged amphiphilic structures are not necessarily required for
antimicrobial activity.
1.4.2 Proposed mechanisms of selectivity
A general mechanism of AMP activity is destabilization of the physical integrity of cell
plasma membranes leading to depolarization, leakage, and eventual cell death [14, 84]. Sup-
port for this comes from studies showing that AMPs composed of D amino acids showed
identical antibacterial and hemolytic activities to their all-L natural versions, indicating spe-
cific interactions with chiral membrane receptors and enzymes are not responsible for activity
[101, 102, 103, 101]. Therefore, membrane disruption is thought to be a consequence of non-
specific interactions between the AMP and the cell membrane. Evidence that AMPs can
directly target lipids, the principal components in cell membranes, comes from an extensive
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Figure 1.11: The fundamental structural motif of antimicrobial peptides. Partitioning of
cationic amino acids (red) and hydrophobic amino acids (green) into distinct regions to
produce an amphipathic molecule. Adopted from ref [14].
33
number of in vitro studies using distinct techniques including X-ray and neutron scattering,
NMR, AFM, Raman spectroscopy, circular dicroism, differential scanning calorimetry, and
flourescence experiments [15] (and references therein). These studies have established that
AMPs strongly interact with and alter the intrinsic structure of lipid bilayers. Furthermore,
numerous leakage assays on liposomes have demonstrated that AMPs can permeabilize lipid
bilayers [15].
AMP selectivity is thought to be a consequence of compositional differences between
bacterial cell membranes and the membranes of the host cells. Microbial cell surfaces are
decorated with polyanionic molecules like lipopolysaccarides in Gram-negative bacteria, and
lipoteichoic acids in Gram-positive bacteria [16]. Additionally, the outer leaflet of bacterial
plasma membranes contains large amounts of anionic lipids such as those with phosphatidyl-
glycerol (PG) and diphosphatidylglycerol (dPG, also called cardiolipin which is abbreviated
as CL) head groups. For example, the membranes of the Gram positive bacteria S. aureus,
and S. pneumoniae (Figure 1.12A) are composed primarly of PG and CL lipids. Phos-
phatidylethanolamine (PE) is the principle zwitterionic phospholipid found in Gram negative
bacteria (Figure 1.12A) such as E. coli, P. aeruginosa, S. typhimurium and in the Gram posi-
tive genus Bacillus [57]. The lipid compositions of animal cell membranes (Figure 1.12B) are
different from bacteria plasma membranes in at least three ways: First, they are more heav-
ily populated by lipids with neutral zwitterionic head groups such as phosphatidylcholine
(PC) and sphingomyelin (SM) [14, 56]. Second, their lipid compositions are asymmetrically
distributed between the inner and outer bilayer leaflets. For example, the primary lipids in
outer leaflet of human erythrocytes are PC and SM, while PE and the anionic lipids phos-
phatidylserine (PS), and phosphatidylinositol (PI) are segregated on the cytosolic side of
the cell [14, 56]. Third, sterols such as cholesterol constitute a major component in mammal
plasma membranes; 1:1 cholesterol:phospholipid by mole [17]. Indeed, numerous in vitro
studies on both natural and synthetic cationic membrane-active antimicrobials have shown
that the presence of anionic lipids increases membrane disruption and permeabilization [15].
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Figure 1.12: Plasma membrane compositions of bacteria and eukaryotic cells. A. On average
the plasma membranes of bacteria cells contain higher amounts of anionic lipids and negative
spontaneous curvature (c0 < 0) lipids. B. Human erythrocyte cells have plasma membranes
typical of eukaryotic cells. They contain less anionic and c0 < 0 lipids and confine them to
the inner leaflet of the plasma membrane. A is adapted from ref [57]. B is from ref [56].
Recently we have shown that the antimicrobial behavior of synthetic phenylene ethynylene
antimicrobial oligomers (AMOs) correlates with their ability to selectively induce topologi-
cal transitions to non-lamellar inverted hexagonal phases in membranes enriched in negative
intrinsic curvature lipids, such as those with PE headgroups [104, 105] and cardiolipin [106].
Finally, membranes enriched with cholesterol are less susceptible to AMPs [107]. Taken
together these results indicate membrane lipid composition plays an important role in AMP
selectivity.
1.4.3 Proposed mechanisms of activity
From in vitro studies, amphipathic AMPs are inferred to disrupt membranes through a
combination of non-specific electrostatic and hydrophobic interactions [14, 15, 69, 16, 108,
107, 109]. In this mechanism the cationic and hydrophobic moieties play complemen-
tary roles. Interaction between the anionic membrane and the cationic AMP leads to a
strong electrostatic attraction and subsequent binding of the AMP to the membrane. Upon
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Figure 1.13: Proposed mechanisms for AMP membrane activity: The toroidal pore model
(left), the carpet model (middle), and the barrel stave model (right). Cartoon adapted from
[15]
adsorption to the membrane the hydrophobic portions of the AMP insert into the non-
polar region of the bilayer leading to membrane destabilization and loss of barrier function
[14, 15, 69, 16, 108, 107, 109]. Based on studies of AMPs with model membranes composed
of single or mixed lipids three models have been previously proposed to describe the insertion
of AMPs into the bilayer: the toroidal pore, carpet, and barrel-stave models [69, 15].
In the toroidal-pore model, (Figure 1.13, left) insertion of peptides into the membrane
eventually induces a self-connection between the two monolayer leaflets, creating a pore that
is lined with both lipid head groups and AMPs. Under specific experimental conditions
toroidal pores have been observed for protegrin-1 [110], melittin [111], and magainin-2 [112,
110] with x-ray and neutron scattering techniques. Similar results were found for protegrin-1
[113], and the synthetic analog of magainin-2, MSI-78 [114], using NMR spectrometry. In
the carpet model (Figure 1.13, middle) the peptides bind and cover the membrane surface
until a threshold concentration is reached. The adsorbed peptides then disintegrate the
membrane in a detergent-like manner into micelles [69]. This model has been used to explain
the membrane activities of the dermaseptins [115, 116], and cecropins [117, 118] since they
exhibit maximal permeation after coating the surfaces of liposomes. In the barrel stave
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model (Figure 1.13, right) the peptides aggregate in the bilayer and then span it to form a
transmembrane pore. The hydrophobic portions of the peptides face the non-polar interior
of the bilayer and the hydrophilic portions are exposed to solution. Results from oriented
circular dichroism [119], neutron scattering [111], and x-ray scattering [120] experiments
suggest that alamethicin induces this type of membrane pore.
However, these three models do not exhaust the types of membrane disruptions that
have been observed for membrane active antimicrobials. There are many ways in which
AMPs can act against bacterial membranes. For example, SEM micrographs of pseudomonas
aeruginosa after a few minutes of exposure to the sheep cathelicidin SMAP29 showed the
presence of large blebs on the bacterial cell surface [15, 121, 122]. Electron microscopy on
cross sections of E. coli after treatment with the antimicrobial parodixin showed significant
surface vesicularization [123]. And electron micrographs show treatment of E. coli cells with
protegrin-1 produces numerous microvilli in the bacterial membrane [124]. It was recently
shown that the pore-forming peptide melittin can induce budding in vesicles by promoting
lipid phase separation [125]. In particular, this last study illustrates that the specific form of
membrane disruption depends on both the peptide and on the physiochemical properties of
the membrane. Overall, the diversity of outcomes suggests that in addition to pore formation
AMPs can destabilize membranes and compromise their barrier function through multiple
processes including blebbing, budding, and vesicularization. Furthermore, the resultant
membrane destabilization mechanism is due to interplay between the unique properties of
both the AMP and membrane. Therefore, it is often the case that a specific type of membrane
destabilization mechanism cannot be described as the membrane mechanism of activity for
an AMP.
While membrane permeation is a general feature of AMP activity, there is emerging
evidence that certain AMPs utilize other mechanisms of microbial killing, as a number of
AMPs have been shown to bind to intracellular targets and consequently inhibit metabolic
processes in bacteria. For example, some AMPs have been shown to directly bind DNA.
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The arginine-rich AMP buforin II from frog was found to penetrate E. coli without lysing
the cell membrane and inhibit cellular functions by binding to DNA and RNA [82]. Tachy-
plesin I from horseshoe crab, which is also arginine-rich, penetrates bacterial membranes
without lysing them and directly interacts with the minor groove of the DNA duplex [126].
And the tryptophan, proline, and arginine-rich bovine AMP indolicidin also kills bacteria
without lysing the cell membrane by binding DNA [126]. Indolicidin is also an inhibitor
of nucleic acid and protein synthesis, and can induce filamentation in E. coli as a result
of preferential inhibition of DNA synthesis [127]. Other AMPs have been shown to inhibit
macromolecular synthesis. The proline and arginine-rich AMP PR39 from pig also halts
synthesis of nucleic acids and proteins which leads to their degradation and bacterial cell
death [128]. In addition to permeabilizing both the outer and inner membranes of E. coli,
human α-defensins HNP-1 and -2 cease DNA, RNA, and protein synthesis [129]. And at
their minimum inhibitory concentrations pleurocidin from flounder and pleurocidin-derived
AMPs can translocate into bacterial cells and exhibit their antimicrobial activities by in-
hibiting macromolecular synthesis [130]. Even though membrane permeabilization is not
a sufficient condition for full antimicrobial activity of certain AMPs, it is still a sufficient
condition for their activity because the peptide must cross the cytoplasmic membrane in
order to reach its internal target. Therefore, membrane interaction remains an important
activity component of non-lytic AMPs, even if their membrane interactions differ from those
of their lytic counterparts.
In addition to their direct antimicrobial abilities many AMPs play other indirect roles
in the host immune response. Mammalian defensins and cathelicidins have been implicated
as modifiers of the innate immunity and in bridging the innate and adaptive immune sys-
tems. HNP-1 and -2 are chemotactic in vitro for human monocytes [131] and T-cells [132],
as well as naive T-cells and immature dendritic cells [133]. Human β-defensins also act as
chemokines, as human β-defensin-2 promoted an adaptive immune response by recruiting
immature dendritic cells and memory T-cells through interaction with human chemokine re-
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ceptor 6 (CCR6) [134], and HBD-3 & -4 are chemotactic for monocytes [135, 136]. Similarly,
the cathelicidins LL37 from human [137], indolicidin from bovine [138], PR39 from pig [139],
and CRAMP from mouse [140] have all been shown to chemoattract various types of leuko-
cytes. Neutrophil α-defensins from human, rat, guinea pig, and rabbit all induced histamine
secretion from mast cells [141], as did HBD-2 and LL37 [142], indicating they can directly
trigger inflammatory response. And HNPs [143, 144] and LL37 [145] stimulate release of
cytokines such as interleukin 8 (IL-8) from epithelial cells and keratinoctyes, respectively.
These results demonstrate that mammalian AMPs have a broad range of immune activation
functions.
Differently, certain AMPs have been associated with the prevention of deleterious ef-
fects to the host from excessive inflammatory response. For example, LL37 partially pro-
tected mice against lethal endotoxic shock induced by high concentration lipopolysaccaride
(LPS) [146]. Both indolicidin and LL37 inhibited LPS-induced tumor necrosis factor al-
pha (TNF-α) release in human macrophage/monocyte-like THP-1 cells indicating they have
antiendotoxin ability [138]. Like other AMPs, both of these cathelicidins can directly bind
to LPS [147], which may prevent proinflammatory cytokine secretion since the neutralized
LPS is unavailable to pattern recognition receptors. However, similar studies showed LL37
and bovine cathelicidin BMAP-27 suppress proinflammatory transcriptional responses in hu-
man monoctyes to LPS [148], suggesting these peptides have multiple endotoxin-neutralizing
activities. Finally, HNPs have been shown to assist cell division in epithelical cells and fi-
broblasts [149], induce epithelial cell proliferation [150], and enhance wound closure [151],
suggesting these peptides have growth-promoting properties which help to counteract the
destructive side-effects of inflammation.
1.4.4 Summary
From the above, it can be seen that there is abundant evidence that AMPs have multiple roles
in host defense. They are generally microbicidal, but many also display specialized immune
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modulation functions. It is known that collectively, AMPs share the fundamental structural
motif of amphiphilicity. A number of natural questions emerge. How does this amphilicity
connect the to specific activity of AMPs against bacterial membranes but not eukaryotic
membranes? Moreover, it is not generally known whether there are additional systematic
patterns in AMP sequences, and how these patterns relate to peptide-lipid interactions
that enable membrane destabilization. Identification of such patterns can in principle lead
to deterministic molecular engineering of AMPs. Finally, how can relatively short simple
amino acid sequences such as those found in AMPs evolve such a broad range of functions?
The purpose of this thesis is to sketch some drafts of answers.
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Chapter 2
Small Angle X-ray Scattering for
Probing the Interactions Between
Macromolecules and Lipid
Membranes
The focus of this thesis is the curvature deformations amphipathic molecules generate in
lipid membranes. In order to resolve structural details the size of the probe must be at least
on the order of the length scale of desired resolution. A typical copper rotating anode source
which uses the CuKα1 emission line produces x-ray radiation with wavelength λ = 1.54045 A˚
[152]. Since the thickness of a lipid bilayer is, t ∼ 4nm, x-ray scattering is an appropriate tool
to characterize lipid membrane structural deformations. By quickly peeking into reciprocal
space to determine the region of interest we see that λ/2t ∼ sinθ ≈ θ. This area of reciprocal
space is often called the small angle regime, and the x-ray technique is called small angle
x-ray scattering.
The liquid crystalline structures that result from self-assembly of biological materials are
somewhat different than the crystalline structures commonly found in atomic solids such as
solid state materials and metals. Liquid crystals are soft, in that the characteristic interaction
energies between molecules are on the order of the thermal energy, kBT . In atomic solids the
inter-atomic interaction energies are usually much greater, and range up to electron volts for
covalently bonded materials [153]. Thermal fluctuations substantially influence the structure
of liquid crystalline systems and the crystals are usually more disordered than atomic solids.
The reduced order in liquid crystalline systems means that the electron density distributions
of the molecules often contribute significantly to the scattering spectra, and it is often easier
to think of these systems in terms of partially ordered distributions of density as opposed to
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discrete lattice vectors.
In this Chapter we first review x-ray scattering with an emphasis on small-angle x-ray
scattering and its application to the structural characterizaton of biologial macromolecule
self-assembly. The presentation and discussion of x-ray scattering is based on references
[154, 155, 156, 157]. Next we summarize a few relevant studies where interactions between
macromolecules and lipid membranes induced phase transitions and membrane curvature.
2.1 Small Angle X-ray Scattering
2.1.1 Formalisms of x-ray scattering
The simplest scattering structure, i.e. composed of more than one unit, is one composed of
two electrons (Figure 2.1). One electron is centered at the origin and the other one is placed
at position r. A plane wave of radiation described by A = A0xˆe
i(k·r−ωt) is incident on the
structure. In the classical picture the electric field of the radiation exerts a force accelerating
the electrons and causing them to radiate the signal in the form of a spherical wave. Here
we assume the scattering is elastic so the emitted radiation has equivalent wavelength to the
incident wave. We wish to determine the path length difference of the radiation from the
two electrons at detector position R.
Assuming the detector distance is very far away, R >> λ, the emitted spherical waves
are essentially plane waves at the detector. The incident wave with wavevector, k where
|k| = 2pi
λ
, arrives at the electron at r after it has scattered from the electron at the origin.
Therefore, the incident phase lag for the incident wave, φin, will be 2pi multiplied by the ratio
of z to the wavelength λ. Since z is the projection of r onto the incident wave, φinc = k · r.
Differently, the scattered wave with wavevector, k’, from the electron at r is ahead the
scattered wave from the electron at the origin by an amount φout = k’ · (R − r) for large
R. Since |k| = |k′| this can be written φout = kR − k’ · r, and the total phase difference is
φ = φin + φout = kR + (k− k’) · r. The field at R is
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Figure 2.1: Schematic of scattering from two electrons. Scattered radiation is approximated
as a spherical wave. For R >> λ the radiation is a plane wave at detector position R. Image
adapted from [158].
A = A0e
i(kR+(k−k’)·r−ωt) (2.1a)
A = A0e
i(kR+Q·r−ωt) (2.1b)
where the momentum transfer vector, Q ≡ k − k’. Calling the angle between k and k’
2θ we have Q = 4pi
λ
sin θ.
This same procedure can be applied to systems with more than two electrons. However
before proceeding we can tidy up this expression by dropping the phase factor kR−ωt, since
a real scattering experiment measures the intensity, which is proportional to the modulus
squared of the complex electic field. Generalizing to an assembly of j electrons with positions
rj the elastic scattering amplitude may be written
A(Q) =
∑
rj
eiQ·rj (2.2)
43
However, in the above equations it is assumed that the positions of the electrons are known
with certainty. Realistically, an electron is described by a (complex) wavefunction, Ψ(r),
where |Ψ(r)|2 corresponds to the probability of finding the particle at position r. Therefore
an assembly of electrons is better described by a distribution specified by a number density
ρ(r). In this case the scattering amplitude becomes
F (Q) =
∫
ρ(r)eiQ·rdr (2.3)
In the limit Q→ 0 the different volume elements scatter completely in phase and F (0) =
Z where Z is the number of electrons. As Q increases the volume elements begin to scatter
out of phase and F (Q → ∞) = 0. Therefore, the scattering signal from a distribution of
electric charge can be calculated from the Fourier Transform of the distribution.
2.1.2 Scattering from lipid bilayers and lamellar phases
Let’s apply equation 2.3 to see what we might expect scattering from an isolated lipid bilayer
to look like. Writing the electron density of a perfect plane as 1(x)1(y)δ(z), the scattering
amplitude in reciprocal space is a line, δ(Qx)δ(Qy)1(Qz). However, lipid bilayers have finite
thickness so a more realistic ‘slab’ model for the electron density of a bilayer with thickness
t may be written ρ(x, y, z) = 1(x)1(y)(H(z) − H(z − t)), where the Heaviside function
H(z), is one for z > 0 and zero otherwise. The scattering amplitude in this case becomes
δ(Qx)δ(Qy) sin(Qzt)/(Qzt). Unlike the thin sheet, since the slab has finite thickness intra-
molecular scattering produces interference effects which are manifested in the modulation
of the scattering amplitude. The scattering amplitude is zero when Qz = 2pin/t, where
n = 1, 2, ..., so the frequency of modulation decreases with decreasing thickness and in the
limit that t→ 0 we recover the thin sheet profile.
Accurate fits of the scattering intensity require better models of the lipid bilayer electron
density distribution. For phospholipids the head group is electron dense while the hydrocar-
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bon tails are not; the hydrocarbon chain region in a phospholipid bilayer has less electron
density than water. Therefore, the bilayer has a non-constant electron density distribution.
A reasonable model for the bilayer electron density approximates the headgroup regions as
two identical Gaussians, and the interior hydrocarbon region as a single Gaussian [159, 160].
The electron density for this 3 Gaussian model may be written:
ρ(z) = ∆ρHe
−(z−zH)2/2σ2H + ∆ρHe−(z+zH)
2/2σ2H + ∆ρT e
−z2/2σ2T (2.4)
This corresponds to a symmetric bilayer centered at z = 0 with peak-to-peak thickness
t = 2zH . The ∆ρi where i = H,T are the electron densities of the headgroup and tail
regions relative to the solution, respectively, and the σ values are their widths. Since the
bilayer electron density is centrosymmetric the Fourier transfrom can be replaced with just
the cosine transform and the scattering amplitude is
F (Q) =
∫
ρ(z) cos(Qz) dz =
(2pi)1/2(2∆ρHσHe
−σ2HQ2/2 cos(QzH) + ∆ρTσT e−σ
2
TQ
2/2) (2.5)
Typically our samples consist of liposomes so the scattering signal is effectively ‘powder
averaged’; all orientations of the bilayer to the incident beam are equally probable. The
diffraction intensity will be proportional to
I(Q) ∝ p(Q)l(Q)|F (Q)|2 (2.6)
The polarization factor, p(Q) = (1 + cos 2θ/2) ≈ 1, for small angle x-ray scattering.
Furthermore for powder samples the Lorentz factor, l(Q) = sin2 θ cos θ, is taken to be 1/Q2.
Figure 2.2A shows the measured SAXS spectra for a solution of small unilamellar vesicles
(SUVs) with lipid composition DOPS/DOPE = 20/80, along with the fit of the data based
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Figure 2.2: Electon density reconstruction of a single lipid bilayer from SAXS spectra of
SUVs. A. Scattering from vesicles composed of DOPS/DOPE = 20/80 lipids shows a broad
feature characteristic of the form factor from lipid bilayers (red curve). The scattering
intensity is fit via nonlinear curve-fitting (Matlab) using the symmetric 3 Gaussian model
plus a power law background: Coefficient/Qn + Constant. B. Bilayer electron density
from the 3 Gaussian model. The peak-to-peak thickness is tpp = 3.80nm. C. Example
lamellar phase SAXS spectra for various lattice spacings based on the DOPS/DOPE =
20/80 lipid bilayer fit from A. As d decreases the peaks shift outward and are modulated by
the form factor. Complete cancellation of the second and fourth order reflections are seen
for d = 4.8nm and d = 5.9nm, respectively.
upon the 3 Gaussian model. Good agreement is seen between the data and fit. The bilayer
electron density corresponding to the fit is shown in Figure 2.2B. As expected the headgroup
electron densities are greater than the surrounding solution, while the electron density of
the hydrocarbon region dips into negative values, indicating that the bilayer interior has less
electron density. Finally the thickness of the bilayer, as measured from the peaks of the
headgroup e-densities, is tpp = 3.80nm, a typical value for a lipid bilayer.
Up to this point we have considered the scattering from isolated assemblies of electric
charge, such as a single lipid bilayer. However, macromolecular assemblies like membranes
often self-assemble into other crystalline phases. This is analogous to atomic solids where
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atoms comprise a crystal. In the model of the diffraction pattern the scattering from an
atomic crystal is built up from the electrons in the atom, then the atoms in the unit cell,
and then finally the cells in the crystal. Since a crystal has translational symmetry, the
position vector can be written as r′j = Rn + rj, where Rn is a lattice vector specifying the
location of a unit cell, and rj is the position of an atom in that unit cell. The scattering
amplitude is then
A(Q) =
unit cell︷ ︸︸ ︷∑
rj
fje
iQ·rn
lattice structure factor︷ ︸︸ ︷∑
Rn
eiQ·Rn (2.7)
The first sum is the unit cell form factor. It describes the scattering from the atoms
within the unit cell. The fj’s are ‘weights’ based upon the electron distributions of the j
th
atom in the cell. The second sum is over the lattice sites of the crystal. Generally, this
structure factor will be large only when Q coincides with a reciprocal lattice vector. Going
back to our isolated membrane, the bilayer electron density corresponds to the unit cell form
factor. The lattice structure factor turned out to be equal to 1 because the single bilayer
occupied the only lattice site.
A commonly observed lyotropic phase is the Lα or lamellar phase. The Lα consists of
stacks of lipid membranes. From a larger perspective the membranes composing the Lα
can be thought of as the different layers in an ‘onion’ multi-lamellar liposome. The electron
density for a lamellar phase with inter-bilayer spacing, d, and N lattice planes can be written
ρLα = ρbilayer(z)⊗ 1(x)1(y)
N/2∑
n=−N/2
δ(z − nd) (2.8)
where ⊗ is the convolution operator. Taking the Fourier transform of this expression,
and noting that the Fourier transform of the convolution of two functions is the product of
their Fourier transforms, we immediately get back a version of equation (2.7). The scattering
amplitude will be
47
ALα(Q) = Fbilayer(Q)
N/2∑
n=−N/2
einQd (2.9a)
= Fbilayer(Q)
sin((N + 1)Qd/2)
sin(Qd/2)
(2.9b)
where the first term is the form factor for the bilayer, and the second term is due to the
crystal lattice sites. The intensity can be written [155]
I ∝|Fbilayer(Q)|
2
Q2
sin2((N + 1)Qd/2)
sin2(Qd/2)
(2.10a)
I ∝|Fbilayer(Q)|
2
Q2
(N + 2
N−1∑
k=1
(N − k) cos(kQd)) (2.10b)
Figure 2.2C shows some example spectra for different lattice spacings, d, using the bilayer
electron density from the fit of the above DOPS/DOPE = 20/80 SUVs, and N = 20. The
structure factor term, sin2((N + 1)Qd/2)/ sin2(Qd/2), reaches a maximum when Qd/2pi =
1, 2, 3..., and Bragg reflections are observed. These reflections are modulated by the form
factor and the effect can be dramatic. For example, for d = 5.9nm, the minimum in the form
factor completely extinguishes the fourth order reflection (Figure 2.2C), while the second
order reflection is absent when d = 4.8nm. Modulation of the structure factor intensities
by the form factor is the basis for electron density reconstruction of the unit cell, which in
this case will be the lipid bilayer and intercalated solution. The integrated intensities of the
reflections ‘sample’ the form factor signal. Their amplitudes can be used as coefficients in
a Fourier series along with the correct choice of phases (±1 for centrosymmetric cells), to
reconstruct the unit cell (see [161, 162] for a more complete discussion).
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2.1.3 Debye-Waller factor
Real molecules do not remain at a fixed spot, but instead experience diffuse motion about
their average position due to thermal agitation. Therefore, the position of nth unit cell is
R′n = Rn + ∆xn where ∆xn is the displacement of the nth unit cell. Referring back to
equation (2.9), we see that the structure factor portion of the scattering amplitude for the
lamellar phase is now
S ′ =
N/2∑
n=−N/2
einQde−iQ∆xn (2.11)
Assuming the average displacements are small, the exponential containing ∆xn can be
expanded as a series
e−iQ∆xn = 1− iQ∆xn −Q2∆x2n/2 + ... (2.12)
We are interested in the average of this quantity. The average of a quantity is the average
of its terms. Since the nth bilayer jiggles around position Rn, 〈∆xn〉 = 0. Neglecting higher
order terms we write
〈e−iQ∆xn〉 = 1−Q2〈∆x2n〉/2 (2.13)
Finally assuming the statistical behavior of the displacements of all the bilayers in the
lattice are equivalent and uncorrelated, the subscript n can be dropped. The structure factor
is now
S ′ =
N/2∑
n=−N/2
einQd(1−Q2〈∆x2〉/2) ≡ S(1−Q2〈∆x2〉/2) (2.14)
This is generally used in the practically equivalent form
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S ′ = Se−〈∆x
2〉Q2/2 (2.15)
So thermal agitation has the effect of reducing the diffracted intensity by an amount
D ≡ e−〈∆x2〉Q2/2 = e−M (2.16)
D is known as the Debye-Waller factor. Since D decreases with Q its effects are more
apparent for higher order reflections. Furthermore, thermal agitation does not broaden
diffraction lines, nor does it change their shape. The above treatment of thermal agitation
was for a 1D lattice built from identical membranes. Generalization to 2 & 3 dimensions
is straightforward [154]. However, in higher dimensions the Debye-Waller factors need not
be isotropic, and the reflections which correspond to the crystal planes that are normal to
the directions of greatest displacements will show the largest reduction in intensity. Finally
if there are several different molecular species in the unit cell each of their Debye-Waller
factors, e−Mj , must be taken into account.
2.2 Previous SAXS Studies of
Macromolecule-Induced Membrane Curvature
2.2.1 Interactions of DNA with phospholipid membranes
Self-assembled complexes of DNA and lipid membranes, so-called ‘lipoplexes’, have recently
garnered much attention as potential gene delivery vectors. The introduction of anionic DNA
to liposomes composed of cationic DOTAP (1,2-Dioleoyl-3-Trimethylammonium-Propane)
and zwitterionic DOPC lipids produces a topological transition to a multi-lamellar structure,
Lcα, with DNA intercalated between adjacent lipid bilayers [65] (Figure 2.3). The average
interaxial spacing between adsorbed DNA was shown to be directly controllable by the
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membrane surface charge density. Upon dilution of DOTAP with DOPC the in-plane DNA
separation continuously increased in a manner consistent with an expanding 1 dimensional
lattice of DNA strands [65, 163]. The release of condensed counterions is responsible for
the higher order of self-assembly. By forming a multi-lamellar structure, the DNA and lipid
neutralize each other and release the 1D and 2D bound counterions in the bulk solution for
a large entropic gain of ∼ 1kBT per released counterion [164].
If the free energy of the cationic lipid-DNA system only depended on electrostatic in-
teractions, the membrane would wrap around the DNA in order to maximize contact and
thereby maximize counterion release. However, there is an energetic penalty associated with
deforming a membrane away from its native state. The Helfrich elastic cost of wrapping
a cylindrical membrane monolayer with radius of spontaneous curvature, R0, and bending
modulus, κ, around DNA with radius, RDNA, is f =
1
2
κ(1/R0−1/RDNA)2 [37]. Therefore, it
is expected that decreasing the bending modulus or enriching the monolayer with negative
spontaneous curvature lipids should reduce the elastic resistance to membrane curvature.
Koltover [37] showed that reduction of the bending modulus via addition of the cosurfac-
tant molecule hexanol [165], or doping the membrane with c0 < 0 DOPE lipids promoted a
Lcα → HcII transition (Figure 2.3). Interestingly, the non-lamellar HcII complexes were more
efficient at transfecting mammalian cells compared with their lamellar counterparts [37].
Lamellar to inverted hexagonal transistions have also been observed in anionic membranes
complexed to DNA through interaction with divalent ions [38]. Unlike the attraction between
cationic lipids and DNA which is mainly due to entropic forces from counterion release,
anionic membrane-DNA complexes rely on multivalent ions to mediate complexation via
direct electrostatic ‘bridging’ attractions [166]. In this system two different lamellar phases
and one inverted hexagonal were observed (Figure 2.4) and the phase behavior was sensitive
to divalent cation type and concentration as well as membrane charge density [38]. In
DOPG/DOPC membranes, Ca2+ and Mg2+ ions promoted complexation of DNA into the
Lcα in membranes with lower anionic charge density, while high DOPG membranes expelled
51
Figure 2.3: Self-assembled lamellar complexes of cationic lipids and DNA undergo a topo-
logical transition to an inverted hexagonal phase via two different pathways: Enriching
the membrane with negative spontaneous curvature lipids (top), or decreasing the bending
modulus by adding a membrane ‘softening’ surfactant (bottom). Figure adopted from [37].
the DNA and assembled into a lamellar phase consisting of membranes ‘glued’ together
with the divalent ions [38]. Zn2+ ions, which are known to non-electrostatically coordinate
lipids and produce membrane curvature, produced DNA-ion-membrane inverted hexagonal
complexes at high Zn2+ concentrations [167]. Therefore, certain divalent ions can be used
as an alternative method to produce membrane curvature.
2.2.2 Phenylene ethynylenes: synthetic antimicrobial compounds
The class of phenylene ethynylene oligomers (AMOs) display potent broad spectrum an-
timicrobial activity against both Gram positive and Gram negative bacteria [168, 169]. By
increasing the oligomer hydrophobic content, homologues of these oligomers can be made
inactive, specifically active against bacterial cells, or non-specifically active against both
bacteria and red blood cells [104]. Previous reports have shown that their activity and selec-
tivity correlates with an AMO-induced topological transition of small unilamellar liposomes
into inverted hexagonal (HII) phases [104]. A crucial membrane component was the con-
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Figure 2.4: The phase behavior of DNA-Zn2+-anionic lipid systems depends on membrane
charge density and [Zn2+]. At very high concentrations Zn2+ induces the HcII phase by
altering the intrinsic curvature of the membrane. Figure adapted from [38].
centration of DOPE lipids. By using vesicles composed of ternary DOPG/DOPE/DOPC
lipids at fixed anionic charge density, the threshold amount of DOPE necessary for HII
formation tracked with oligomer activity [104]. The inactive oligomer did not induce a topo-
logical transition over the entire range of tested membrane DOPE content (Figure 2.5A).
The selectively active oligomer induced inverted hexagonal phases in membranes with high
concentrations of DOPE only (Figure 2.5B), while drastically less membrane DOPE content
was required for generation of the HII phase by the non-specifically active oligomer [104]
(Figure 2.5C). Since the cell membranes of Gram negative bacteria are composed of much
greater amounts of DOPE than the plasma membranes of eukaryotic cells, these results im-
ply there is a relationship between negative spontaneous curvature lipids such as DOPE,
oligomer hydrophobic content, and selective antimicrobial activity. Moreover, the ability
to generate non-lamellar membrane curvature is important to the mechanism of action for
phenylene ethynylene antimicrobials. Similar results were observed in membranes enriched
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Figure 2.5: Generation of inverted hexagonal phases by antimicrobial phenylene ethynylene
compounds correlates with their activity and selectivity. A. The inactive AMO-1 did not
substantially restructure liposomes. B&C. The selectively active AMO-2 induced HII phases
in PE-rich membranes only, while the non-specifically active AMO-3 required much less
membrane PE content to induce the HII . D. AMO-n structures. Increasing hydrophobicity
increases their potency. E. Cross section of the HII phase. The AMOs are colored blue.
Figure adapted from [104].
in cardiolipin, a major lipid component in the membranes of Gram positive bacteria, pro-
vided the solution contained low millimolar concentrations of biologically prevalent divalent
Mg2+ or Ca2+ cations [106]. Since bound divalent cations can change the approximately
zero spontaneous curvature of cardiolipin to negative values these results are consistent with
the role of negative spontaneous curvature lipids in AMO activity [106].
A direct link between negative spontaneous curvature lipids and AMO bactericidal ac-
tivity was shown via in vitro killing assays [105]. A PE-knockout mutant of E. Coli was
much less susceptible to membrane-active phenylene ethynylenes than the wild-type bacte-
54
ria, but much more vulnerable when treated with the antibiotic tobramycin which is known
to target the bacterial ribosomal machinery and is not membrane-active [105]. Since PE
deletion is usually a lethal mutation, these results suggest one possible reason why bacterial
resistance is more difficult to attain for this class of membrane-active antimicrobials than
for conventional antibiotics [170, 169].
2.2.3 Prototypical arginine-rich cell-penetrating peptide: The
TAT peptide
Cell-penetrating peptides are cognate to antimicrobial peptides. They comprise a class of
short (< 20 amino acid) cationic peptides that have the ability to traverse the cell mem-
branes of many different types of mammalian cells. A wide variety of macromolecules have
been attached to these peptides and subsequently internalized. Moreover, after uptake the
cargo maintains its activity. The ability of cell-penetrating peptides to translocate biologi-
cally active molecules into cells makes these peptides promising candidates for drug delivery
applications. While much controversy still surrounds their uptake mechanism, the emerg-
ing body of evidence suggests cell-penetrating peptides use multiple mechanisms to enter
cells [171]. They can directly cross membranes [172, 173, 174, 175, 176]. They can also
employ the cell’s endocytotic machinery for translocation, as studies have shown uptake via
clatharin-mediated endocytosis [177, 178, 179], caveolin-dependent endocytosis [180, 181],
and macropinocytosis [182, 183, 184].
The most widely studied cell-penetrating peptide, the TAT peptide from the HIV trans-
activator protein is an 11 amino acid sequence peptide which has a net charge of +8 from
6 arginines and 2 lysines [185]. Arginine has an essential role in the translocation abilities
of the TAT peptide. Substitution of any basic residue in the TAT peptide with a neutral
alanine substantially reduces its activity while replacing one of the uncharged residues with
alanine has no effect, indicating that the high positive charge of the TAT peptide is a neces-
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sary for its activity [185, 186]. However, cationicity is not a sufficient condition. Polyarginine
sequences with sufficient length display equivalent or better uptake compared with the TAT
peptide [187, 188]. However, homopeptides of lysine, histidine, and ornithine with the same
charge as the TAT peptide cannot enter cells.
Previous work has shown that the HIV TAT cell-penetrating peptide generates negative
Gaussian membrane curvature, the type of membrane curvature found in pores, protrusions
from macropinocytosis, invaginations from endocytosis [189]. Using synchrotron small angle
X-ray scattering (SAXS), it was demonstrated that the TAT peptide (amino acid sequence:
YGRKKRRQRRR) generates a cubic Pn3m ’double-diamond’ phase (Figure 2.6A,C,&D) in
membranes enriched with negative intrinsic curvature lipids [189]. Similar features are seen
in the presence of 100 mM NaCl indicating that TAT peptide can generate these dramatic
changes in membrane topology at physiological salt conditions (Figure 2.6A).
If the generation of negative Gaussian curvature is correlated with cell-penetrating pep-
tide permeation ability, then peptides that are unable to penetrate cells should not induce
membrane phases with negative Gaussian curvature. Experiments with polylysine, K8, on
membranes of identical composition to those used for TAT peptide, show interactions be-
tween the lipid head groups and polylysine induce wrapping of the membrane monolayers
[189] (Figure 2.6B). The result is an inverted hexagonal phase where the much smaller colum-
nar channels are filled with peptide and solution. This phase has negative mean curvature
but zero Gaussian curvature. The absence of negative Gaussian curvature may explain the
poor transduction ability of polylysine.
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Figure 2.6: Generation of saddle-splay membrane curvature correlates with the uptake abil-
ities of cell-penetrating peptides. A. The archetypal arginine-rich cell-penetrating peptide,
the TAT peptide, generated a bicontinuous Pn3m cubic phase rich in saddle-splay curvature.
B. Poly-lysine, which is known to have poor cell-penetrating ability, generated only inverted
hexagonal phases which have negative mean curvature but zero Gaussian curvature. Illus-
trations of the minimal surface, C, and the non-intersecting water channels, D, of the Pn3m
cubic phase. Figure adapted from [189, 171].
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Chapter 3
Criterion for Amino Acid
Composition of Defensins and
Antimicrobial Peptides Based on
Geometry of Membrane
Destabilization
3.1 Introduction
Antimicrobial peptides (AMPs) comprise an important component of the innate host defense
system. Collectively, AMPs have broad spectrum antimicrobial activity [14, 15, 69, 84]. Al-
though AMPs are diverse in sequence and structure, most share two general structural
features: they are amphipathic and cationic [14, 15]. From in vitro studies, AMP amphi-
pathicity is inferred to disrupt membranes through a combination of electrostatic interac-
tions of the cationic AMP with the anionic membrane followed by insertion of hydrophobic
patches into the non-polar interior of the bilayer [14, 15, 69, 108, 107, 109]. Membranes can
be disrupted by AMPs via a diverse range of processes, including pore formation, blebbing,
budding, vesicularization [14, 15, 69, 84, 108, 107, 109, 77, 75, 76, 191, 123]. This diversity
of outcomes has impeded the development of a detailed, molecular understanding of how
AMPs destabilize bacterial membranes specifically. Such knowledge can in principle provide
design rules that impact development of synthetic antimicrobials.
Mammals produce two main types of membrane active AMPs: defensins, [77, 75, 76]
and cathelicidins [191]. Defensins comprise a potent class of membrane disruptive AMPs
with well-characterized broad spectrum and selective microbicidal effects. Defensins are
0Much of this chapter is also discussed in: Schmidt, et al. JACS (2011) 133, 6720, or [190]
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synthesized by varied epithelia and by phagocytes, and function as a biochemical line of
defense against microbial infection [77]. Vertebrate defensins share general features, includ-
ing cationic charge, MW of 2-5 kDa, distinctive tridisulfide arrays, and β-strand structures
constrained by the disulfide pairings [75, 76]. They can be separated into three subfamilies,
α-defensins, β-defensins, and θ-defensins [75]. Since many aspects of defensin biology are
known, this is an ideal prototypical family of AMPs to investigate the detailed molecular
mechanisms responsible for selective activity against bacterial but not mammalian mem-
branes.
In the first part of this chapter we use synchrotron small angle x-ray scattering (SAXS) to
map out the fundamental curvature deformation modes induced in model cell membranes by
defensins, and elucidate causative relationships between curvature deformations and mem-
brane disruption processes. Mammalian defensins are systematically investigated, using
members from the three defensin subfamilies, including rhesus monkey θ-defensin-1 (RTD-
1), baboon θ-defensin-7 (BTD-7), mouse Paneth cell α-defensin cryptdin-4 (Crp-4), human
β-defensin-2 (HBD-2), and human β-defensin-3 (HBD-3). The bactericidal activity of these
defensins is correlated with the induction of saddle-splay (equivalently negative Gaussian)
membrane curvature. All peptides restructured vesicles into porous bicontinuous phases rich
in saddle-splay curvature when lipid compositions mimic those of bacterial membranes, but
not when the lipid compositions are more representative of mammalian membranes. These
results are shown to be consistent with vesicle leakage assays. A key parameter for activity
is the concentration of negative intrinsic curvature (c0 < 0) lipids, such as those with PE
headgroups, which exist at significantly higher concentrations in bacterial cytoplasmic mem-
branes compared to eukaryotic membranes. Existence of homologous behavior in synthetic
antimicrobials, [104, 105, 106] suggests a common root mechanism for selective membrane
permeation. A mechanism of action based on saddle-splay membrane curvature generation
is broadly enabling, since it is a necessary condition for processes such as pore formation,
blebbing, budding, vesicularization, all of which destabilize the barrier function of cell mem-
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branes [192]. In general, AMPs destabilize membranes via a diverse range of processes, many
of which involve saddle-splay curvature.
Saddle-splay membrane curvature generation places constraints on the amino acid com-
position of membrane disruptive peptides. In the second part of this chapter we show that
the topological requirement for membrane destabilization implies that a decrease in arginine
content in an AMP can be offset by an increase in both lysine and hydrophobic content.
This criterion for amino acid compositions of AMPs based on the generation of saddle-splay
curvature is consistent with trends in the amino acid composition of 1,080 known cationic
AMPs. Lastly we demonstrate the consistency of this ‘design rule’ by showing that α-helical
peptides with little homology to defensins also generate saddle-splay membrane curvature.
3.2 Experimental Section
3.2.1 Preparation of peptides
Recombinant Crp4 was expressed and purified as His6-tagged fusion proteins as described
[193, 194, 195]. Expression of recombinant fusion proteins was induced by adjusting ex-
ponentially growing E. coli BL21-CodonPlus (DE3)-RIL cells to 0.1 mM isopropyl-β-D-1-
thiogalactopyranoside and incubating at 37◦C for 6 h in Terrific Broth as described in earlier
reports. Cells were lysed by sonication in 6 M guanidine-HCl, 100 mM Tris (pH 8.0), and
the suspension was clarified by centrifugation. His6-tagged fusion proteins purified by nickel-
nitrilotriacetic acid resin affinity chromatography (Qiagen, Valencia, CA) were cleaved with
cyanogen bromide and purified by analytical C18 reverse phase high pressure liquid chro-
matography (RP-HPLC). Peptide homogeneity was confirmed in analytical acid-urea poly-
acrylamide gel electrophoresis (AU-PAGE), a highly sensitive measure of defensin foldamers.
Molecular masses were verified by matrix-assisted laser desorption ionization-time of flight
mass spectrometry (MALDI-TOF MS) and peptides were quantified using extinction coef-
ficient calculations at 280nm performed at ExPASY [196]. θ-defensins RTD-1 and BTD-7
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were produced by solid phase synthesis, purified and characterized as described previously
[197, 198]. HBD-2 and HBD-3 are expressed and purified as described in [199, 200].
3.2.2 Liposome preparation for x-ray measurements
DOPC (1,2-dioleoyl-sn-glycero-3- phosphocholine), DOPE (1,2-dioleoyl-sn-glycero-3- phos-
phoethanolamine), DOPG 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt),
and DOPS 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt), lyophilized lipids from
Avanti Polar lipids were used without further purification. For x-ray experiments we pre-
pared Small Unilamellar Vesicles (SUVs) by sonication. DOPG, DOPS were dissolved in
chloroform/methanol, and DOPC, DOPE were dissolved in chloroform for stock solutions.
Mixtures of DOPG and DOPE were prepared at 1:4 mass ratio to approximate bacterial lipid
compositions, while DOPS, DOPC, and DOPE at 1:4:0, and 1:2:2 mass ratios were used to
approximate the membranes of eukaryotic cells. Lipid mixtures were dried under N2, dessi-
cated overnight under vacuum, and resuspended at a final concentration of 20 mg/ml in
Millipore H2O. Solutions were incubated at 37
◦C overnight and then sonicated until clear.
SUVs were obtained via extrusion (0.2 µm pore Nucleopore filter).
3.2.3 SAXS experiments
Defensin and lipid solutions were thoroughly mixed at specific peptide to lipid ratios (P/L)
and sealed in quartz capillaries. All samples were prepared in 100-150 mM NaCl to simulate
physiological salt conditions. For SAXS experiments at the Stanford Synchrotron Radia-
tion Laboratory (BL4- 2) and at the Advanced Photon Source (BESSRC-CAT BL-12IDC),
monochromatic X-rays with energies of 9-11 and 12 keV, respectively, were used. Scattered
radiation was collected using a MAR Research CCD area detector (pixel size, 79 µm). Sam-
ples were checked for consistency by multiple measurements with different x-ray sources.
No radiation damage was observed for the incident beam intensities and the exposure times
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used. 2D SAXS powder patterns were integrated using the Nika 1.2 package [201] and FIT2D
[202].
3.2.4 Vesicle dye leakage experiments
Giant Unilamellar Vesicles (GUVs) were prepared using the swelling method. Stock solutions
of lipids DOPS, DOPE, and DOPC in chloroform were deposited (100µl at 20mg/ml) at the
desired mass ratios onto roughened, cleaned Teflon, along with dye DiO (10mul at 1mg/ml).
After drying under vacuum the Teflon was hydrated with moist nitrogen gas for 30min, and
then 5ml swelling solution was added (100 mM sucrose plus 20µM Alexa 633 maleimide),
and incubated for 2 days at 37◦C. After swelling, the GUV suspension was diluted 40x into
200mM glucose. 200µl of this dilution was placed on a coverslip soaked in 1% BSA, and
Crp4 (10µl at 1 mg/ml) was added. A Leica SP2 laser scanning confocal microscope was
used.
3.2.5 Analysis of data from the antimicrobial peptide database
Data was obtained via the online antimicrobial peptide database [203, 204]. Comparison of
helical peptides with defensins: Eligible peptides were required to be active against Gram-
negative or Gram-positive bacteria. A pool of 299 peptides with helix structure is compared
with a pool of 143 defensins. “Average% of AMP composition” is the number of times an
amino acid is found in a pool divided by the total number of amino acids in that pool.
Lysine/arginine ratio versus %Hydrophobicity: Eligible peptides were required to have
a net positive charge and be active against either Gram-negative or Gram-positive bacteria.
Percentage of lysine, %K, and percentage of arginine, %R, were read off from the sequence
information for a set hydrophobic bin. Here %K (%R) = Number of lysines (arginines) found
in the bin/Total number of amino acids in the bin. Note that %K/%R = NK/NR (defined
below). Lysine/arginine ratio versus 〈Hydrophobicity〉: Eligible peptides were required to
62
have a net positive charge and be active against either Gram-negative or Gram-positive
bacteria. These criteria retrieved a pool of 1,080 peptides. For a given peptide, j, its average
hydrophobicity is defined by:
〈Hydrophobicity〉j ≡ 1
n
n∑
i=1
ωi (3.1)
Where n = number of amino acids in the peptide, ωi = the hydrophobicity of the ith
amino acid in the peptide. This value is set by the particular hydrophobicity scale used. To
facilitate easier comparison across scales, the value of the apparent free energy of membrane
insertion for an amino acid, ∆Gaaapp, based upon the Wimley-White biological scale was
reversed in sign, i.e. ∆Gaaapp → −∆Gaaapp. The published hydrophobicity values were used for
all other scales. To partition each peptide into a bin the hydrophobic extremes for the pool
were determined and used to set the range of hydrophobicity scale. The range was divided
into 100 equal bins. For the M peptides in a given bin, we define:
NK
NR
≡
M∑
j=1
(number of K)j
M∑
j=1
(number of R)j
(3.2)
NK/NR versus 〈Hydrophobicity〉 is plotted for each of the 100 bins.
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Figure 3.1: The θ-defensins used in this study: rhesus θ-defensin-1 (left) and baboon θ-
defensin-7 (right). Cationic arginines are colored blue, and the hydrohobic amino acids are
colored yellow.
3.3 Results
3.3.1 θ-Defensins generate saddle-splay curvature in model
bacterial membranes with high PE concentrations but not
in model eukaryotic membranes with low PE
concentrations
θ-defensins are short 18 amino acid circularized peptides expressed only in old world monkeys
and orangutans [77]. Previous in vitro studies have shown both rhesus θ-defensin-1 (RTD-
1) and baboon θ-defensin-7 (BTD-7) (Figure 3.1) have activity against Gram-positive and
Gram-negative bacteria, and fungi [197, 79]. Moreover, RTD-1 has antiviral activity against
HIV-1 [205], and the herpes simplex virus [206]. Both θ-defensins are amphipathic and
contain five arginine residues.
Small Unilamellar Vesicles (SUVs) with phospholipid compositions characteristic of Gram-
negative bacteria (DOPG/DOPE = 20/80) were incubated with specific defensins to study
the induced structural changes. Synchrotron SAXS profiles from lipid solutions only showed
a broad characteristic feature consistent with a single lipid bilayer form factor expected for
unilamellar vesicles (see Supporting Information, Figure S1). When exposed to RTD-1 or
BTD-7 (Figure 3.2A&B), the vesicles underwent a drastic structural transition and displayed
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characteristic correlation peaks with ratios,
√
2 :
√
3 :
√
4 :
√
6, which indicate the forma-
tion of a cubic Pn3m double-diamond lattice. By fitting the slopes of the measured Q-values
at every peak we calculate lattice parameters, aBTD−7 = 16.00 nm, and aRTD−1 = 15.98
nm, for BTD-7 and RTD-1, respectively1. The Pn3m (Figure 3.2C) is a bicontinuous cubic
phase where two non-intersecting water channels are separated by a lipid bilayer [53]. The
center of the bilayer traces out a minimal surface with negative Gaussian curvature at every
point. Although bilayer saddle-splay curvature is different than the self-connected monolayer
saddle-splay curvature seen in a toroidal pore (Figure 3.2D), it should be noted that each
constituent monolayer in a bicontinuous phase also possesses negative Gaussian curvature
at every point, and is equally accessible by AMPs. On such saddle-shaped surfaces (Figure
3.2C), the surface curves upwards in one direction and downwards in the perpendicular di-
rection. For example, saddle-shaped surfaces are found inside toroids, which have a single
hole each. This type of curvature is not found on the surfaces of spheres, which lack holes.
Furthermore, protrusions such as buds and blebs (Figure 3.2D), require bilayer saddle-splay
curvature at their base. Saddle-splay curvature is required for membrane poration, as well
as for formation of different AMP-induced destabilization mechanisms depicted in Figure
3.2D.
To examine the role of membrane intrinsic curvature on induced saddle-splay curvature
we constructed ternary lipid membranes of constant anionic charge (DOPG = 20%) but with
varying ratios of DOPE (c0 < 0) and DOPC (c0 ≈ 0). In contrast to effects on PE-rich mem-
branes, RTD-1 and BTD-7 did not restructure vesicles that mimic eukaryotic membranes
with low concentrations of PE. Phases rich in saddle-splay curvature were not induced by
RTD-1 or BTD-7 in membranes with DOPG:DOPE:DOPC = 20:40:40 (Figure 3.2A&B),
as indicated by the absence of their characteristic correlation peaks. The diffraction data
1While coexisting phases (such as lamellar and inverted hexagonal phases) are sometimes observed at
specific lipid compositions the observed reflections cannot be accounted for without the presence of a Pn3m
cubic phase. The strong induced formation of cubic phases like the Pn3m which are rich in saddle-splay
curvature is a generic feature in the full phase diagram of defensin-lipid structures.
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Figure 3.2: Generation of negative Gaussian curvature by θ-defensins is dependent on
membrane PE concentration. At peptide to lipid molar ratio, P/L = 1/30, both RTD-
1 (A) and BTD-7 (B) θ-defensins, induced a Pn3m cubic phase in SUVs with lipid
compositions mimicking the cell membranes of Gram-negative bacteria, DOPG/DOPE =
20/80, but not in membranes with reduced amounts of negative intrinsic curvature lipids,
DOPG/DOPE/DOPC = 20/40/40. Insets in A&B show indexation of the Pn3m cubic phase
by agreement between the measured peak Q positions and the Miller indices h, k, l, with
relationship Qmeas = 2pi
√
h2 + k2 + l2/a, for a cubic phase with lattice parameter, a. (C)
(upper left) Illustration of the Pn3m cubic phase. The surface at the mid-plane between
bilayer leaflets has zero mean curvature and negative Gaussian curvature at every point.
(lower right) Negative Gaussian curvature requires positive curvature (+) in one direction
and negative curvature (−) in the perpendicular direction to locally produce a saddle shape.
(D) Diagrams of different manifestations of saddle-splay curvature in the interior of a pore
(1) and at the base of blebs (2), buds (3), and rod-like projections (4). Figure adopted from
[190].
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showed a combination of broad form factor scattering characteristic of isolated bilayers and
a lamellar phase with a periodicity of dRTD−1 = 5.67 nm and dBTD−7 = 5.67 nm for RTD-1
and BTD-7, indicating that weak inter-membrane attraction is induced, although curvature
is not.
It is important to discriminate between necessary and sufficient conditions for saddle-
splay curvature generation. Alamethicin [207], gramicidin S [208], and protegrin-1 [209],
form cubic phases in pure PE lipids under specific processing conditions such as temperature
cycling. The above results on defensins allow us to assess systematically the roles played
by different lipid species. It has been previously proposed that anionic lipids in bacterial
membranes are important for AMP function. We agree with this assessment. However, while
anionic PG lipids and high curvature PE lipids in the target membrane are both necessary
conditions for induction of saddle-splay curvature, neither by itself is a sufficient condition
(see Supporting Information, Figure S2). Our data suggests that AMPs target distributions
of lipids rather than individual lipid species.
3.3.2 Arginine-rich α-defensins also generate saddle-splay
curvature in membranes enriched with PE and selectively
permeate PE-rich GUVs
To investigate whether other arginine-rich defensins exhibit similar behavior we conducted
similar experiments on mouse cryptdin-4 (Crp-4) (Figure 3.3), a 32 amino acid α-defensin
expressed in mouse Paneth cells with in vitro microbicidal activity against Gram-negative
and Gram-positive bacteria [210, 211]. Crp-4 is amphipathic and 7 of the 10 cationic amino
acids in Crp-4 are arginine residues [212]. Like the θ-defensins, the α-defensin Crp-4 gener-
ated saddle-splay curvature in model bacterial membranes with high PE but not in model
eukaryotic membranes with low PE. Incubation of Crp-4 with SUVs of high PE lipid com-
position produced a Pn3m cubic phase with lattice parameter, a = 11.1 nm (Figure 3.4A),
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Figure 3.3: Solution structure of mouse Paneth cell alpha-defensin Crp-4 (protein data bank
ID 2GW9) obtained by NMR. Crp4 sequence: GLLCYCRKGHCKRGERVRGTCGIRFLY-
CCPRR. A. Structure shown in worm rendering. The three disulfide bonds from 6 cysteines
are displayed in orange, and β-sheets are represented by purple arrows. Blue regions denote
cationic amino acids (arginine, lysine, and histidine), while the anionic glutamic acid is red.
B Space filled structure illustrates the cationic (blue) and hydrophobic (yellow) patches of
amphipathic Crp-4. Neutral residues are colored grey. From [213].
while reduction of membrane DOPE content led to the disappearance of the Pn3m cubic
phase.
Interestingly, previous work suggests that negative intrinsic curvature lipids can promote
pore formation through modification of the Gaussian modulus [51, 50]. As discussed in sec-
tion 1.2.8, the Gauss-Bonnet theorem shows the formation of a toroidal pore in a membrane
changes the Gaussian curvature, K, in the membrane by an amount ∆
∫
K · dA = −4pi, so
the free energy change from pore formation is ∆E = κG∆
∫
K · dA = −4piκG. Typically the
bilayer Gaussian curvature modulus, κbG, is negative, which exacts a free energy penalty for
pore formation. In section 1.2.8 it was shown (equation 1.5) that κbG is
κbG = 2(κG − 4κc0d) (3.3)
Here κG (< 0, from the lateral stress profile of the monolayer) is the Gaussian curvature
modulus of the monolayer, κ (> 0) is the monolayer bending modulus, c0 is the spontaneous
curvature of the monolayer, and d (> 0) is the distance from the middle of the bilayer to the
monolayer pivot point [50]. Usually the negative value of the monolayer Gaussian curvature
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Figure 3.4: The α-defensin Crp-4 showed similar phase behavior to θ-defensins which sug-
gests a general mechansim for selectivity by defensins rich in arginine. At P/L = 1/45, Crp-4
induced a Pn3m cubic phase in DOPS/DOPE = 20/80 membranes, but induced a lamellar
phase with lattice spacing, a = 6.0nm in DOPS/DOPE/DOPC = 20/40/40 membranes.
Figures B and C show representative GUVs after treatment with Crp-4. Dye leakage oc-
curred in vesicles enriched with DOPE (B), but not in vesicles enriched with DOPC (C),
consistent with the relationship between membrane PE content and the creation of porous
phases by defensins. White scale bars are 10µm. Figure from [190].
modulus ensures that κbG remains negative, and pore formation is energetically unfavorable.
However, negative intrinsic curvature lipids (c0 < 0) such as PE change the bilayer Gaus-
sian curvature modulus toward positive values [51]. The decreased free energy barrier to
changes in membrane topology toward porous phases is consistent with our observation that
membranes rich in negative intrinsic curvature lipids are more susceptible to pore formation.
Our x-ray experiments measure AMP-induced curvature deformations in a 3D lipid sys-
tem, which has the freedom to connect into bulk phases such as the Pn3m. Both eukaryotic
and prokaryotic cells have quasi-2D membranes, where induced saddle-splay curvature de-
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formations can take the form of pores, blebs, or buds. To determine how peptide-induced
saddle-splay curvature is manifested in 2D membranes we investigated the effect of Crp-4
on giant unilamellar vesicles (GUV) by confocal microscopy. Liposomes with lipid com-
positions mimicking the membranes of bacteria (PS/PE = 20/80) and of eukaryotic cells
(PS/PC = 20/80) were loaded with maleimide dye and incubated with Crp-4 (molar ratio
P/L=1, see Experimental Section). Dye leakage was evident in PE-rich membranes after
peptide exposure (Figure 3.4B), consistent with Crp-4 induced pore formation in the intact
vesicles. In contrast, negligible dye leakage was observed in PC-rich vesicles (Figure 3.4C).
Selective permeation of GUVs rich in PE but not PC is consistent with the observation of
pore-enabling Crp-4 induced saddle-splay curvature (Figure 3.4A) from SAXS experiments.
Taken together, these results indicate Crp-4 preferentially creates pores in membranes with
negative intrinsic curvature lipids.
3.3.3 Generality of mechanism for defensins and relation of
curvature generation to antimicrobial peptide sequence:
HBD-2 and HBD-3 as examples
We hypothesized the selective induction of saddle-splay curvature in model bacterial mem-
branes is a generic feature among defensins. We used human β-defensin-2 (HBD-2, DEFB4)
and human β-defensin-3 (HBD-3, DEFB103A) [214], to test this hypothesis (Figure 3.5).
HBD-2 is a 41AA amphipathic peptide [215], which is predominately effective against Gram-
negative bacteria [199]. HBD-3 is 45AA, amphipathic, and is generally more potent than
HBD-2 [214, 216]. Unlike the other two defensin subfamilies which strongly favor argi-
nine over lysine, β-defensins have intermediate arginine to lysine ratios [76]. In HBD-3 the
cationic residues consist of 7 arginines and 6 lysines, and HBD-2 has 2 arginines, 5 lysines,
and 1 histidine.
Figure 3.6 shows the SAXS spectra of model bacterial and model eukaryotic membranes
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Figure 3.5: Structures of human β-defensin-2 (protein data bank ID 1E4Q), and
human beta defensin-3 (protein data bank ID 1KJ6). HBD-2 with sequence:
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP, is shown on the left.
HBD-3 with sequence: GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKC-
CRRKK, is on the right. Cationic amino acids are colored blue, anionic amino
acids are red, hydrophobic amino acids are yellow, and neutral residues are gray.
Images rendered using the macromolecular structure viewer Cn3D, from website:
http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml
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after exposure to HBD-2 and HBD-3. The capacity for membrane-specific saddle-splay cur-
vature generation is observed, and is consistent with behavior of θ-defensins and α-defensins.
Both β-defensins showed weak interactions with membranes enriched with DOPC, and pro-
duced lamellar phases in membranes with intermediate amounts of PE/PC (Figure 3.6A&B).
In DOPS/DOPE = 20/80 membranes, HBD-2 generated a Pn3m cubic, with lattice parame-
ter a = 13.8 nm (Figure 3.6A). HBD-3 also generated saddle-splay curvature in DOPS/DOPE
= 20/80 membranes, which is exhibited in reflections with ratio,
√
6 :
√
8 :
√
14 :
√
16, char-
acteristic of the cubic Ia3d ‘gyroid’ phase with a = 18.0 nm (Figure 3.6B). Like the Pn3m,
the Ia3d is a bicontinuous cubic phase consisting of two non-intersecting water channels sep-
arated by a single lipid bilayer which has saddle-splay curvature everywhere on its minimal
surface [41].
3.3.4 Average induced saddle-splay curvature, 〈K〉, from SAXS
measurements allows quantitative comparison of different
antimicrobial peptides
Our previous work on cell penetrating peptides [189, 171], has shown lysine and arginine
generate different types of membrane curvatures. Since lysine and arginine are cationic they
both induce wrapping by anionic membranes. As explained in the Wet Electrostatics section
(1.3), this is due to the entropy of counterions condensed on both the charged membrane and
on the short charged polymers. Electrostatic compensation between a cationic polymer [217]
and an anionic membrane [63] leads to the release of condensed counterions into the bulk
solution and a corresponding large entropy gain, which results in strong polymer-membrane
binding. This has been observed in a large number of systems [65, 218, 219]. Since maximal
contact between the peptide and membrane leads to maximal counterion release, the mem-
brane will tend to wrap around the peptide generating negative curvature [220, 37]. The
guanidine group of arginine supports multi-dentate hydrogen bonding, which can organize
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Figure 3.6: β-defensins with intermediate arginine/lysine ratios also generated negative
Gaussian curvature. Neither HBD-2 (A) or HBD-3 (B) produced cubic phases in membranes
with low PE concentrations. In DOPS/DOPE/DOPC = 20/40/40 membranes, HBD-2 and
HBD-3 restructured SUVs into lamellar phases with lattice spacings d = 6.2nm and 7.0nm,
respectively, and DOPS/DOPC = 20/80 membranes showed only weak interaction with both
β-defensins. Conversely, in DOPS/DOPE = 20/80 membranes HBD-2 induced coexisting
Pn3m and inverted hexagonal (lattice spacing a = 7.5nm) phases, while HBD-3 induced an
Ia3d cubic phase. P/L = 1/35 for HBD-2, and 1/55 for HBD-3. (C) Comparision of the
average negative Gaussian curvature, 〈K〉, produced in 80% PE membranes by AMPs rich
in arginine (left group) and by AMPs with both lysines and arginines (right group) around
the peptide to lipid isoelectric point. The inset in each bar graph corresponds to the number
of arginines in the AMP. Figure from [190].
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bulky lipid head groups to generate positive curvature in the perpendicular direction, result-
ing in saddle-splay curvature (Figure 3.7). In contrast, the amine group of lysine can only
hydrogen bond to one lipid head group at a time [221, 222]. Consistent with this, polylysine
induces negative mean curvature on membranes to form inverted hexagonal phases, while
polyarginine can also induce saddle-splay curvature to form cubic phases. Clearly more work,
experimental, theoretical, and computational, is required for a full understanding of these
effects. Extant theoretical studies [223, 224, 225] suggest the anisotropy associated with
saddle-splay curvature deformations may also provide AMPs with a way to communicate
and organize cooperatively.
The Pn3m, Ia3d, and Im3m cubic phases are related by a Bonnet transformation, so their
average Gaussian curvatures can be quantitatively compared [53, 41]. Recall (equation 1.9)
that the average Gaussian curvature is 〈K〉 = 2piχ
a2A0
, where a is the cubic lattice constant, χ is
the Euler characteristic, and A0 is the surface area per unit cell. Figure 3.6C shows the 〈K〉
values extracted from the diffraction data for arginine-rich defensins (RTD-1, BTD-7, Crp-4)
and protegrin-1 (PG-1) [74], (see Supporting Information, Figure S3). A correlation exists
between negative Gaussian curvature and arginine content in structurally similar peptides.
HBD-2 and HBD-3, which have ∼50% lysines and ∼50% arginines, clearly deviate from this
curve, although 〈K〉 is more negative for HBD-3 compared with HBD-2, consistent with the
greater number of arginines in HBD-3.
3.3.5 The requirement of saddle-splay membrane curvature
generation places strong constraints on amino acid
composition of antimicrobial peptides: the saddle-splay
curvature selection rule
Defensins can generate pores [75, 77, 76], but AMPs have been observed to disrupt mem-
branes via processes that do not involve pores. Generation of the required saddle-splay
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Figure 3.7: Illustration of the hydrogen bonding abilities of arginine and lysine with lipid
headgroups. The guanidinium group of arginine (left) can form multiple hydrogen bonds
with lipid headgroups leading to positive curvature generation. The amino group of lysine
(right) can only hydrogen bond to a single lipid headgroup at a time and, therefore, cannot
generate positve curvature.
membrane curvature for these processes places strong constraints on the amino acid compo-
sition and composite hydrophobic and cationic components of membrane disruptive peptides.
Hydrophobic amino acids generate positive curvature [108, 107, 226]. Non-polar components
of the amphipathic peptide are inserted into the membrane, which increases the hydropho-
bic volume of the perturbed lipid monolayer and thereby creates positive curvature strain.
Differences in lipid headgroup chemistry will not drastically affect this mechanism.
Cationic amino acids work differently. We have demonstrated lipid head group organi-
zation by arginine and lysine generates distinct types of membrane curvature deformations.
These interactions provide an AMP with complementary curvature producing mechanisms.
Arginine generates negative Gaussian curvature (positive and negative curvatures along the
two perpendicular principal directions), whereas lysine generates negative curvature along
one direction only (Figure 3.7). Mechanisms of curvature generation based on head group
re-organization are inherently sensitive to head group chemistry, therefore such mechanisms
will be conducive to mediating specific peptide-lipid interactions.
Based on the above, a series of rules governing the amino acid content of membrane
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disruptive antimicrobial peptides can be proposed. A decrease in arginine content in a
peptide sequence will imply that less negative Gaussian curvature can be generated. This
can in principle be compensated for by an increase in both lysine and hydrophobic content.
This ‘exchange rate’ concept between arginines and lysines/hydrophobes is illustrated in a
comparison between the amino acid content2, of β-sheet bonded defensins and that of α-
helical AMPs (Figure 3.8A&B). The average arginine composition of α-helical AMPs is∼50%
that of defensins, but the proportion of most hydrophobic amino acids in α-helical AMPs
is ∼200% that found in defensins (Figure 3.8A). Likewise, whereas most of the hydrophilic
amino acids are found in similar proportions for α-helical AMPs and defensins, the proportion
of lysines in α-helical AMPs has drastically increased by ∼300% relative to that in defensins
(Figure 3.8B). Thus, there is a unifying conceptual link between α-helical AMPs and β-sheet
AMPs: β-sheet AMPs generally rely more on arginines to generate curvature, while α-helical
AMPs rely more on lysines and hydrophobes to do so. In both cases, the end result is the
generation of saddle-splay curvature.
Within a more general compass, a strong manifestation of this ‘saddle-splay curvature
selection rule’ for amino acid content can be observed in the compositions of AMPs. We test
this selection rule against 1,080 known cationic peptides with activity against Gram positive
or Gram negative bacteria [203]. Figure 3.9A shows a plot of NK/NR (the ratio of the number
of lysines to the number of arginines) vs %Hydrophobic (% of hydrophobic amino acids in
peptide, see Experimental Section), in which all AMPs have been binned into 7 histograms.
A strong increasing trend consistent with the saddle-splay curvature selection rule can be
discerned. Figure 3.9B-D shows a similar analysis of AMP amino acid sequences using more
sophisticated measures to quantify peptide hydrophobicity, using three established scales
(Kyte-Doolittle [227], Eisenberg consensus [228], Wimley-White biological [229]), in which
2In Figure 3.8 we exclude the amino acids cysteine, proline, and glycine which primarily influence AMP
tertiary structure and are not directly involved in the cationicity or hydophobicity of AMPs. Also we
consider only arginine and lysine in our exchange rate concept since they constitute the vast majority (89%)
of cationic AA found in the 1,080 AMPs.
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Figure 3.8: The exchange of R with K and hydrophobicity is illustrated by comparing β-sheet
defensins with α-helical AMPs. (A) On average defensins contain much greater amounts of
R than α-helical AMPs, and utilize less of each type of hydrophobic amino acid. (B) Overall,
the proportion of hydrophilic amino acids is comparable in defensins and α-helical AMPs.
The exception is K, which is more commonly found in α-helical AMPs. Blue denotes basic
amino acids, while negatively charged amino acids are colored red. Figure from [190].
all AMPs have been partitioned into 100 bins. A strong positive correlation is observed
between hydrophobicity and logNK/NR. Even though we do not account for effects due to
proximate amino acids, sequence, and peptide conformation in our simple approach, there
is strong exponential-like dependence between hydrophobicity and NK/NR, consistent with
the saddle-splay curvature selection rule.
3.3.6 Demonstration of the generality of curvature generation by
antimicrobial peptides: α-helical AMPs melittin and
magainin-2 generate saddle-splay curvature
To test the consistency of the saddle-splay curvature selection rule similar SAXS studies
were performed on the α-helical AMPs melittin and magainin-2. Melittin is a 26 amino acid
peptide expressed in the European honey bee [230, 231]. It is the principle component of bee
venom and displays potent membrane-lytic activities against both eukaryotic and bacteria
cells [231, 232, 233]. Magainin-2 is a 23 amino acid host-defense peptide isolated from the skin
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Figure 3.9: Demonstration of the exchange between R, with K and hydrophobicity based
upon 1,080 cationic AMPs in the antimicrobial peptide database. (A) By organizing all 1,080
AMP sequences into 7 histogram bins, a strong positive dependence between the peptide
lysine to arginine ratio and peptide hydrophobicity percentage can be observed. More robust
calculations of hydrophobicity based upon the widely used Kyte-Doolittle (B), Eisenberg
Consensus (C), and Wimley-White (D) hydrophobicity scales show the same relationship
between the exchange of arginine with lysine and hydrophobicity consistent with the saddle-
splay curvature selection rule. See Experimental Section for details and binning schemes in
B-D. Figure from [190].
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of the African clawed frog [72]. Magainin-2 exhibits broad spectrum antimicrobial activity
against numerous species of Gram postive and Gram negative bacteria and fungi, and is
non-hemolytic at microbicidal concentrations [72, 234]. Circular dichroism experiments on
both melittin [235] and magainin-2 [236] have shown that while they are unstructured in
solution, both peptides adopt α-helical conformations upon contact with membranes. The α-
helical secondary structure partitions their cationic and hydophobic residues onto opposing
faces of the helix rendering them amphipathic. Melittin is highly hydrophobic (46% by
%Hydrophobic) and has 3 lysines and 2 arginines that are mostly clustered at the peptide
C-terminal. Magainin-2 is less hydrophobic (39% by %Hydrophobic) than melittin and has
4 lysines and a histidine. In line with expectations both melittin and magainin-2 induced
saddle-splay curvature in model bacteria membranes. Melittin generated a Pn3m cubic
phase with lattice parameter a = 18.2nm, and magainin-2 generated a Pn3m cubic phase
with lattice parameter a = 17.9nm. Therefore, α-helical antimicrobials with little homology
to the β-sheet defensins can also induce saddle-splay membrane curvature.
3.4 Conclusions
The saddle-splay curvature selection rule is consistent with different mechanisms of bar-
rier disruption such as budding, blebbing, pore formation, vesicularization. However, as
described in section 1.4.3, many AMPs have additional antimicrobial functions other than
membrane permeation. For example, indolicidin [237], buforin [82], and tachyplesin [126]
are also known to bind internal targets in bacteria such as DNA. Mammalian α- and β-
defensins, and cathelicidin LL-37 play other important functions in host defense including
modulation of the innate immune response and wound repair [76, 238]. A necessary and suf-
ficient condition for membrane disruption is not a necessary and sufficient condition for full
antimicrobial activity, which may involve other mechanisms such as DNA binding. (They
may share related amino acid requirements, since both membrane activity and DNA bind-
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Figure 3.10: α-helical antimicrobial peptides can generate negative Gaussian curvature. In
DOPS/DOPE = 20/80 membranes both melittin (A) and magainin-2 (B) restructured SUVs
into cubic phases. At P/L = 1/40 melittin induced the Pn3m phase, while coexisting Pn3m
and inverted hexagonal (indexes in green, lattice spacing 7.7nm) phases were induced by
magainin-2 at P/L = 1/60.
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ing require high cationic charge density.) It should be noted however, that AMPs which kill
bacteria by binding to interior elements must first permeabilize the cytoplasmic bacterial
membrane to reach the target. Since negative Gaussian curvature is topologically required
for pore formation we expect the saddle-splay curvature selection rule should also apply to
non-lytic AMPs provided that membrane permeation is necessary for their function, even if
it isn’t a sufficient condition for full activity.
In a more general context, the saddle-splay curvature selection rule we propose does
not strongly restrict the amino acid content of an AMP, since it affects only the arginine,
lysine, and hydrophobic residues. Membrane destabilizing AMPs therefore inherently have
significant sequence flexibility for beneficial mutations. Consistent with this observation, it
is known that AMP amino acid sequences are fairly non-conserved and labile across species
[14]. However, when they acquire specific functions, such as Fe homeostasis activity in the
hepcidins [239], their sequences tend to stabilize. That 1080 known AMPs are consistent
with the saddle-splay curvature selection rule suggests that they all have some degree of
membrane curvature generating activity, but since the selection rule under-determines the
full sequence, there is potential for AMPs to acquire new functions, such as optimized DNA
binding.
The saddle-splay curvature selection rule ultimately originates from geometry, so the
amino acid composition trends are expected to be general for a broad range of membrane-
active peptides. For example, the fusion protein M2 from the influenza virus induces in
vitro cell membrane budding and scission. It contains a 17 residue amphipathic helix with
comparable amino acid content to AMPs and is capable of inducing budding in GUVs [240].
During virion release M2 localized to the neck of budding virions, the region of maximal
negative Gaussian curvature [171, 240]. This suggests other membrane-active peptides and
proteins utilize similar strategies to generate curvature in membranes.
In summary, we show that a broad range of defensins and α-helical peptides selectively
permeate bacterial membranes by inducing saddle-splay membrane curvature in a manner
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that depends on target membrane lipid composition. Since the presence of saddle-splay cur-
vature is necessary for membrane-disrupting processes, generation of saddle-splay membrane
curvature by AMPs is a versatile mechanism of action. A saddle-splay curvature selection
rule that places strong constraints on the amino acid composition of membrane disruptive
peptides is deduced. We believe this rule can guide the rational design of antimicrobials.
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Figure S1: SAXS measurements on membranes used in this study show broad features
consistent with the form factor from lipid bilayers indicating the presence of SUVs. Samples
are in 100mM NaCl solution. Figure from [190].
Figure S2: RTD-1 interacts differently with different lipid species. Virtually identical scatter-
ing profiles for DOPE only and DOPE+RTD-1 demonstrate RTD-1 weakly interacts with
DOPE, and does not drastically reorganize DOPE lipids. RTD-1 strongly interacts with
DOPG, and mediates adhesion between DOPG membranes into a Lα lamellar phase with d
= 5.3nm. Replacement of DOPG with DOPS gives similar results. Since RTD-1 generates
a Pn3m cubic phase only in composite DOPG:DOPE membranes this indicates both lipids
play an essential role in curvature generation. Figure from [190].
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Figure S3: Generation of negative Gaussian curvature by protegrin-1 requires less mem-
brane PE content. Protegrin-1 (PG-1) is an 18 amino acid amphipathic cathelicidin which
resembles θ-defensins both sequentially and structurally. All six of its cationic residues are
arginine, and its sheet structure is largely conferred from two intra-disulfide bonds from four
cysteine residues. (A) PG-1 restructures vesicles with high amounts of PE, DOPG/DOPE =
20/80, and reduced amounts, DOPS/DOPE/DOPC = 20/70/10, into coexisting Pn3m and
Im3m cubic phases. For the 80% PE condition (B), aPn3m = 11.91 nm and aIm3m = 15.02
nm, with ratio aPn3m/aIm3m = 1.26, which is close to the Bonnet ratio of 1.279 for coexisting
cubic phases, and (C) aPn3m = 13.7 nm and aIm3m = 17.5 nm, for the 70% PE condition
(C). The calculated lattice parameters, a, for the coexisting cubic phases show a increases
with decreasing PE. Since a is inversely related with the amount of negative Gaussian cur-
vature, K, this implies large K is easier to produce in PE rich membranes. (D) None of
the defensins measured at DOPS/DOPE/DOPC = 20/70/10 induced a cubic phase. Crp-4,
BTD-7, and RTD-1 generate lamellar phases, d = 5.7nm, 5.9nm, and 5.7nm, respectively,
with zero Gaussian curvature in membranes with reduced PE. The lower threshold PE con-
centration necessary for PG-1 to generate cubic phases may explain its reduced specificity
compared with defensins. P/L = 1/30, for PG-1, RTD-1, and BTD-7, and 1/45 for Crp-4.
Figure from [190].
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Chapter 4
Saddle-Splay Curvature Generation
Tracks With Antimicrobial Activities
of R→K Variant α-Defensins
4.1 Introduction
Mammalian α-defensins are an important mediator of the host innate immune response.
Their common characteristics include ∼4kDa size, a β-sheet secondary structure conferred
by three invariant disulfide bonds via cysteine residues, cationic net charge and amphipathic
character [77, 76, 75]. Activity assays have demonstrated that, in vitro, α-defensins display
collective broad spectrum microbicidal activity against a variety of pathogens including
Gram-positive and Gram-negative bacteria [241, 211, 242], fungi [243], protozoa [244] and
enveloped viruses [194]. While some α-defensins have adopted additional indirect roles in the
immune response [131, 132, 141], most are directly antibacterial. An established mechanism
for the direct antibacterial effects of α-defensins is selective membrane disruption [245, 246,
247] which leads to permeation, depolarization, leakage, and eventual cell death.
In Chapter 3 it was shown that the membrane curvature deformations produced by de-
fensins were sensitive to lipid composition. Defensins selectively generated membrane desta-
bilizing saddle-splay curvature only in model bacteria membranes. Furthermore, arginine,
lysine, and hydrophobicity are the curvature generating ingredients in a defensin. Therefore,
membrane curvature depends on both the biophysical properties of the membrane and the
cationic and hydrophobic properties of the defensin. Defensin sequences have been naturally
engineered to produce disruptive mechanisms such as pore formation in the membranes of
deleterious microbes. The idea of a ‘sweet spot’ for membrane disruption necessarily implies
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Figure 4.1: Ribbon model of the α-defensins used in this study. Wild type Crp4 and (R/K)
Crp4 are shown on the left, and RMAD4 and (R/K) RMAD4 are on the right. Cationic
amino acids are depicted using ball and stick form. Used with permission from K. Tai.
sequence optimization by tailoring the destabilizing curvature deformations produced by a
defensin to coincide with microbial membrane compositions. It is therefore expected that
certain alterations of defensin sequence and structure will shift the sweet spot for maximal
membrane disruption.
In a recent study Llenado et al [211] showed that lysine for arginine substitutions in
two different broad spectrum antimicrobial α-defensins, crytpdin-4 (Crp4) from mouse and
rhesus myeloid α-defensin-4 (RMAD4), had different effects on their in vitro microbicidal
profiles. In Crp4, R→K replacements generally attenuated activity, while the effects of anal-
ogous substitutions in RMAD4 ranged from having a neutral effect to modestly improving
activity against certain bacteria. Since both α-defensins are known to permeabilize lipid
membranes, these results provide a baseline to understand how well variations in defensin
bactericidal activity are tracked by the curvature deformations these peptides induce in
model membranes.
In this chapter we use synchrotron small-angle x-ray scattering (SAXS) to characterize
the lyotropic liquid crystalline phases that wild type and R→K variants of α-defensins Crp4
and RMAD-4 induce in model liposomes. By varying the biophysical properties of the mem-
brane through changes in lipid composition we probe the curvature deformations produced
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by each α-defensin as a function of both the membrane properties and peptide arginine and
lysine content. The resulting defensin-lipid membrane phase diagrams are then compared
with microbicidal assays to examine the relationship between the molecular length scale cur-
vature deformations defensins generate in membranes and their killing abilities. We show
the curvature deformations induced by both defensins agree with their bactericidal activi-
ties. In Crp4, R→K substitutions drastically changed the phase behavior, whereas R→K
substitutions in RMAD4 had little effect on curvature generation. Our results provide an ex-
planation for the differences that lysine for arginine substitutions have on the killing abilities
of these α-defensins.
4.2 Results
4.2.1 R→K substitution in Crp4 drastically shifted cubic phase
generation to membranes with reduced DOPE content
Small unilamellar vesicles were prepared with membranes composed of negatively charged
DOPS and zwitterionic DOPE and DOPC lipids and then incubated with α-defensins. Since
the spontaneous curvatures (c0) of both DOPS and DOPC are approximately zero, while
DOPE has c0 < 0, ternary mixtures of these lipid types allow the membrane anionic sur-
face charge density and monolayer spontaneous curvature to be independently varied. It
is believed that distribution differences of the lipids found in the membranes of microbes
compared with host cells, such as increased amounts of both anionic lipids and negative
spontaneous curvature lipids in bacterial plasma membranes, allow defensins to specifically
target microbial membranes [14].
Representative spectra of the WT Crp4 and the lysine for arginine substituted Crp4
mutant defensin (R/K) Crp4, are shown in Figure 4.2A. Both Crp4 and (R/K) Crp4 in-
duced a variety of structure factor correlation peaks indicating both peptides substantially
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restructured DOPS/DOPE/DOPC membranes. Furthermore, the observed liquid crys-
talline phases strongly depend on membrane lipid composition. In DOPS/DOPE/DOPC
= 20/60/20 membranes (Figure 4.2A) Crp4 induced reflections with peak Q positions at
ratio 1:2, indicating Crp4 reorganized 60% DOPE liposomes into multi-lamellar phases
with lattice spacing d = 5.80nm. Multi-lamellar phases consist of stacks of locally flat
membranes in which the Crp4 is likely intercalated between adjacent bilayers. In mem-
branes with increased amounts of negative spontaneous curvature lipids, DOPS/DOPE =
20/80, two additional sets of correlation peaks appear with ratios 1 :
√
3 :
√
4 :
√
7 and
√
2 :
√
3 :
√
4 :
√
6 :
√
8, indicating the presence of coexisting inverted hexagonal and Pn3m
cubic phases. By relating the measured Q peak positions to their Miller indices h, k, l,
for each phase, QHexmeas = (4/
√
3)
√
(h2 + k2 + hk)/a, and QCubemeas = 2
√
(h2 + k2 + l2)/a, the
lattice parameters are calculated via linear trendline fit to be aHex = 7.68nm and aPn3m =
16.40nm for the inverted hexagonal and Pn3m cubic phases, respectively.
The Pn3m is a bicontinuous ‘double-diamond’ cubic phase where the lipid bilayer divides
space into two non-intersecting tetrahedral water channels. The center of the bilayer, where
the tail regions of the constituent lipid monolayers meet, traces out a minimal surface which
has zero mean curvature and negative Gaussian curvature at every point. In other words, any
point on a minimal surface has principle axes of curvature c1 = −c2, so the mean curvature,
H = 1
2
(c1 + c2) = 0, while the Gaussian curvature, K = c1c2 < 0. Geometrically, the surface
will curve upwards in one direction and downwards in the perpendicular direction, locally
giving it the shape of a saddle. Negative Gaussian (or equivalently saddle-splay) curvature
is found in the interior of a toroidal pore, at the ‘neck’ of membrane budding events, as well
as at the base of membrane blebs and other protrusions. Since it is topologically necessary
for different membrane destabilization processes, generation of negative Gaussian curvature
by Crp4 is a potent mechanism to disrupt the barrier function of cell membranes. Like
the Pn3m, the inverted hexagonal, HII , is also a non-lamellar phase. The HII is a two
dimensional lattice of hexagonally coordinated cylindrical tubes. Each tube consists of a
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Figure 4.2: Small-angle x-ray scattering showed substitution of lysine for arginine in the
α-defensin cryptdin-4 (Crp-4) substantially changed phase behavior. A. Crp-4 induced
non-lamellar cubic (a = 16.4nm) and inverted hexagonal (a = 7.74nm) phases in PE-rich
DOPS/DOPE = 20/80 membranes, but not in membranes with reduced amounts of nega-
tive intrinisic curvature lipids B. (R/K) Crp-4 generated a pure inverted hexagonal phase
(a = 7.09nm) at DOPS/DOPE = 20/80, and coexisting cubic (a = 19.3nm) and inverted
hexagonal (a = 7.68nm) phases in DOPS/DOPE/DOPC = 20/60/20 membranes. Scattering
spectra in A & B are at peptide/lipid = 1/45 molar ratio except for Crp-4 at DOPS/DOPE
which is at P/L = 1/67. The insets show indexation of the Pn3m cubic phases. C and
D. DOPS/DOPE/DOPC = 20/x/(80-x) phase diagrams where x = %DOPE, for Crp-4 and
(R/K) Crp-4, respectively. Replacing arginine with lysine in Crp-4 decreased the threshold
PE concentration necessary to produce non-lamellar cubic and inverted hexagonal phases.
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central water channel that is wrapped by a lipid monolayer. The monolayer is oriented such
that the lipid headgroups remain hydrated. Since the lipid monolayer bends toward the
water along the direction of wrapping, c1 < 0, and is flat along the tube axis, c2 = 0, HII
phases have negative mean curvature and zero Gaussian curvature at every point.
Figure 4.2B shows the analogous scattering spectra for (R/K) Crp4. In membranes with
lipid composition DOPS/DOPE = 20/80, (R/K) Crp4 induced a pure inverted hexago-
nal phase with lattice parameter a = 7.09nm, indicating that the lysine-rich variant peptide
generated only negative mean curvature in membranes enriched in negative spontaneous cur-
vature lipids. When the membrane DOPE content was decreased to DOPS/DOPE/DOPC =
20/60/20, coexisting Pn3m cubic, a = 19.3nm, and inverted hexagonal phases, a = 7.68nm,
were observed. Therefore, (R/K) Crp4 generated negative Gaussian curvature in membranes
with reduced amounts of negative spontaneous curvature lipids.
Comparisons of the phase diagrams of Crp4 (Figure 4.2C) and (R/K) Crp4 (Figure
4.2D) reveal the drastic effect replacement of arginine with lysine has on the curvature
generating abilities of Crp4 α-defensin. For Crp4, non-lamellar cubic and inverted hexagonal
phases are observed only at the highest membrane 80% DOPE composition, consistent with
previous reports on its phase behavior [190]. At lower PE content flat membrane multi-
lamellar phases are seen, indicating > 70% DOPE is necessary to induce non-zero curvature
phases. Conversely, (R/K) Crp4 generated both negative Gaussian curvature and negative
mean curvature in membranes with DOPE as low as 60%. While coexisting cubic, inverted
hexagonal, and multi-lamellar phases are present at 80% DOPE for Crp4, (R/K) Crp4
induced only an inverted hexagonal phase. In ternary DOPS/DOPE/DOPC = 20/x/(80-
x) membranes the phase progression produced by Crp4 with increasing x = DOPE% is
Lα → QII → HII , similar to that found in temperature studies on lyotropic systems [248,
249, 250, 50]. The effect of R→K substitution in Crp4 is to reduce the amounts of negative
spontaneous curvature lipids that are required for topological transitions to non-lamellar
phases.
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4.2.2 R→K replacements in RMAD4 did not substantially
change phase behavior
To see if lysine for arginine replacements have similar effects on other α-defensins we per-
formed comparable experiments on the α-defensin RMAD4. Representative spectra for wild
type RMAD4 are shown in Figure 4.3A. Coexisting Pn3m, a = 13.3nm, and Im3m, a =
17.0nm, cubic phases in addition to an inverted hexagonal phase, a = 7.44nm, were gener-
ated at DOPS/DOPE = 20/80 membrane compositions demonstrating that RMAD4 also
induces negative Gaussian curvature and negative mean curvature in membranes rich in
PE. Like the Pn3m, the Im3m ‘plumber’s nightmare’ is a bicontinuous cubic phase where
the lipid bilayer mid-plane traces out a minimal surface which divides space into two non-
intersecting water channels. However, their morphologies differ. For example, in the Im3m
the water channel junctions have six vertices, different from the tetrahedrally coordinated
(four vertices) water channel junctions of the Pn3m. The ratio of the Im3m and Pn3m lat-
tice parameters aIm3m/aPn3m = 1.278, is close to the theoretically predicted Bonnet ratio of
1.279, indicating both cubic phases have identical negative Gaussian curvature distributions
on their surfaces which is expected for coexisting phases. When the membrane negative
spontaneous curvature lipid composition is reduced to DOPS/DOPE/DOPC = 20/60/20,
the non-lamellar phases disappear and are replaced by a multi-lamellar phase with lattice
spacing d = 6.99nm (Figure 4.3A). Therefore, like Crp4, RMAD4 only generates nega-
tive Gaussian curvature and negative mean curvature in membranes with elevated levels of
DOPE.
The spectra for (R/K) RMAD4 closely resemble the wild type peptide (Figure 4.3B). In
DOPS/DOPE = 20/80 membranes (R/K) RMAD4 generated coexisting Pn3m, a = 18.2nm,
and inverted hexagonal, a = 7.42nm, phases. The Pn3m cubic phase lattice parameter for
RMAD4 is smaller than for (R/K) RMAD4 (13.3nm versus 18.2nm). Since the average nega-
tive Gaussian curvature, 〈K〉, is inversely proportional to the square of the lattice parameter,
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Figure 4.3: Lysine for arginine substitutions in the α-defensin RMAD4 did not significantly
affect phase behavior. A. Small angle x-ray scattering spectra showed that RMAD4 gen-
erated coexisting non-lamellar cubic (Pn3m a = 13.3nm, Im3m a = 17.0nm) and inverted
hexagonal (a = 7.42nm) phases in DOPS/DOPE = 20/80 membranes but not in membranes
with reduced amounts of DOPE. B. (R/K) RMAD4 also generated non-lamellar cubic (Pn3m
a = 18.2nm) and inverted hexagonal (a = 7.42nm) phases in PE-rich membranes just like
wild type RMAD4. Spectra in A & B are at peptide/lipid = 1/80 molar ratio, and the insets
show indexation of the cubic phases The phase diagrams of RMAD-4, C, (R/K) RMAD4,
E, and an α-defensin with intermediate R→K, (R1,2,5,33/K) RMAD-4, D, are very similar.
This indicates that, unlike Crp-4, replacement of arginine with lysine in RMAD-4 has little
effect on the curvature generating abilities on RMAD4. Phase diagrams in C, D, & E, are
DOPS/DOPE/DOPC = 20/x/(80-x) where x = %DOPE.
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this indicates that R→K substitution decreased the amount of negative Gaussian curvature
generated by RMAD4. However, the phase behavior of the two peptides is very similar;
they both induce negative Gaussian and negative mean curvature in PE-rich membranes.
Furthermore, multi-lamellar phases with lattice spacing, d = 7.04nm are observed for (R/K)
RMAD4 and DOPS/DOPE/DOPC = 20/60/20 membranes (Figure 4.3B), similar to WT
RMAD4. These results indicate that substitution of lysine for arginine has much less effect
on the membrane curvature deformations produced by RMAD4 than for Crp4.
Figure 4.3C-E shows the phase diagrams for RMAD4, (R/K) RMAD4, and a peptide
with partial R→K substitutions in sequence positions 1, 2, 5, and 33, (R1,2,5,33/K) RMAD4.
Like in the Crp4 and (R/K) Crp4 phase diagrams, the general phase progression of Lα →
QII → HII with increasing DOPE membrane content is also seen for the RMAD4 peptides.
Moreover, the peptide to lipid (P/L) ratio also affects phase behavior as increasing the P/L
tends to promote non-lamellar cubic and hexagonal phases. However, in striking contrast
to Crp4 peptides, R→ K substitutions do not significantly affect the phase behavior of the
RMAD4 peptides. For all three peptides, the presence of non-zero curvature phases begins
around 60% DOPE content. Cubic and inverted hexagonal phases rich in negative Gaussian
curvature and negative mean curvature, respectively, dominate at 70% and 80% DOPE.
Taken together, the x-ray data show that while R→K substitutions drastically change the
membrane curvature deformations induced by Crp4, similar cationic residue substitutions in
RMAD4 have little effect on its membrane curvature generating abilities.
4.3 Discussion and Conclusion
All the defensins examined in this study induced non-lamellar cubic phases and inverted
hexagonal phases specifically in membranes enriched in PE lipids, compositions that resem-
ble bacterial cell membranes. Since negative Gaussian curvature is topologically required for
a number of membrane destabilization processes, generation of negative Gaussian curvature
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membrane deformations is a potent way to disrupt cell membranes. Negative mean curvature
is a necessary condition but not a sufficient condition for negative Gaussian curvature. How-
ever, negative mean curvature membrane deformations are also topologically active, which
implies these curvature deformations likely assist in membrane disruption. Indeed, previous
studies have shown a correlation between the antibacterial activity of synthetic and natural
membrane active antimicrobials and their ability to induce inverted hexagonal phases in lipo-
somes [104, 105, 106]. By specifically generating membrane destabilizing negative Gaussian
curvature and negative mean curvature in model bacterial membranes, Crp4 and RMAD4
and their R→K variants exploit innate compositional differences between the membranes of
bacteria and eukaryotic cells that render bacteria membranes more vulnerable to disruption.
How might the observed changes in the curvature deformations from R→K substitutions
in Crp4 lead to attenuated bactericidal activity? An important function of Crp4 in innate
host defense is selective membrane disruption, so its composition is likely under positive
selection for potent membrane activity against bacterial membranes. Altering the Crp4
sequence with R→K substitutions necessarily alters how it deforms membranes because
arginine and lysine generate different types of membrane curvature. The curvature producing
abilities of (R/K) Crp4 are not matched with bacterial membranes so they are no longer
able to optimally destabilize them. The negative Gaussian curvature generation ‘sweet spot’
has shifted out of the bacterial membrane region to lower amounts of membrane PE. In the
membrane lipid compositions where Crp4 generated negative Gaussian curvature, (R/K)
generates negative mean curvature. The result is a peptide which retains activity yet is
attenuated compared to the wild type.
The shift of non-lamellar phase generation by (R/K) Crp4 to membranes with reduced
amounts of negative intrinsic curvature lipids is due to the differing curvature generating
tendencies of arginine and lysine. Arginine can generate negative Gaussian curvature while
lysine can only generate negative mean curvature. The effect of R→K substitution in Crp4
is to remove positive curvature. Therefore, inverted hexagonal phases are observed instead
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of cubic phases in PE-rich bacterial membranes for (R/K) Crp4. Since PE is a negative
spontaneous curvature lipid it reduces the energetic penalty of wrapping membranes into
inverted hexagonal phases. Less membrane PE content makes it harder to wrap, which is
why cubic phases appear at lower membrane PE concentrations. The differences between
the dependence of Crp4 on arginine for generating negative Gaussian curvature, and the
indifference of RMAD4 to R→K substitutions is likely due to how the molecules present
their cationic charge when interacting with membranes. The surface distribution of the
arginines in Crp4 is confined to one face of the molecule that runs along the major axis,
while the arginines in RMAD4 are mostly confined to one face along the minor axis (Figure
4.1). If the interaction of the guanidine group of arginine with lipid headgroups is sufficiently
obstructed, its bidentate hydrogen bonding ability may diminish to the point that it behaves
like lysine.
In summary our results establish a connection between the killing abilities of α-defensins
and the curvature deformations they induce in membranes. The changes in phase behavior
due to R→K substitutions in Crp4 and RMAD4 track with their in vitro microbicidal profiles.
Replacement of lysine for arginine generally attenuated Crp4 bactericidal activity. X-ray
characterization of Crp4 and (R/K) Crp4 showed that the lysine-rich mutant generated
topologically active curvatures over a different range of lipid compositions compared to the
wild type, implying its curvature generating abilities are no longer optimized for killing
bacteria. Differently, the bacterial killing abilities of RMAD4 and (R/K) RMAD4 ranged
from being the same to slightly better for the lysine-rich version. The phase diagrams of
RMAD4, (R/K) RMAD4, and (R1,2,5,33/K) RMAD4 are highly similar indicating that R→K
substitutions have minor effect the membrane curvature deformations produced by this α-
defensin. Since variations in α-defensin bactericidal activities show good correspondence
with their phase behaviors, we believe the curvature generating tendencies of membrane
active antimicrobials are useful predictors of AMP activity.
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4.4 Materials and Methods
4.4.1 Liposome preparation for x-ray measurements, and SAXS
experiments
Liposomes were prepared as described in section 3.2.2. X-ray samples were prepared and
measured as described in section 3.2.3 except for the following changes. All samples were
prepared in 100mM NaCl solution. SAXS experiments were collected at Stanford Syn-
chrotron Radiation Laboratory (BL4-2). The scattered radiation was collected using a Ray-
onix MX225-HE detector (pixel size, 73.2µm).
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Chapter 5
Investigation of the Membrane
Activities of Guanidine-Rich
Molecular Transporters and
Antimicrobials Based Upon
Saddle-Splay Curvature Generation
5.1 Introduction
Utilization of arginine to help confer strong interactions with cell membranes is found in a
number of membrane-active peptides and proteins. For example, hydrophilic arginine-rich
cell penetrating peptides (CPP) such as the TAT peptide from the HIV transactivator pro-
tein TAT can efficiently translocate across cellular membranes [185, 188, 251, 222, 252, 253].
And certain classes of antimicrobial peptides (AMPs) like amphipathic α- and θ- defensins
from mammals, which display potent in vitro activity against bacteria via membrane per-
meabilization, overwhelmingly use arginine over lysine [75, 76, 77]. Due to their biological
relevance and complex interactions with cell membranes much scientific effort has gone into
understanding the observed structure-function relationships between arginine-rich peptides
and biomembranes.
There is substantial evidence that the unique membrane interacting properties of arginine
are due to its guanidine side chain. In cell penetrating peptides, previous studies have shown
that cationic charge is a necessary but not a sufficient condition for activity. While poly-
arginine can enter cells similar length lysine, histidine, and ornithine peptides all showed poor
transduction ability [187, 186, 188]. Heptamers of cationic citrulline, an isotere of arginine
with a single oxygen for nitrogen replacement in the guanidine group also cannot enter
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cells [187]. Identification of a guanidinium functional group as the essential part of arginine
for cell-penetrating ability initiated development of a variety of synthetic guanidinium-rich
oligomers, many of which display better uptake than their peptidic relatives. Oligoarginine
peptoids were more efficient at entering cells than oligoarginine peptides [186]. Faster uptake
was observed for guanidinium-rich oligocarbamates than TAT peptide [254]. Polyguanidino
dendrimers based on diamino acid monomeric units were also taken up by cells [255], and
carbohydrate-based polymers like guanidinylated neomycin can penetrate cells and deliver
bioactive macromolecules [256]. These results not only implicate the importance of the
guanidinium group, they also demonstrate that synthetic oligomers containing guanidinium
have a rich potential for applications such as drug delivery vectors and antibiotics.
Chapters 2&3 discussed how arginine is unique in its ability to generate destabilizing
membrane curvatures. The strong electropositive charge along with the planer Y-shape
structure of guanidine [221] equips arginine with the ability to generate complementary types
of membrane curvature. Multivalent cations such as poly-arginine generally promote elec-
trostatic wrapping of anionic membranes, while the structure of guanidine supports multi-
dentate hydrogen bonding with multiple lipid headgroups [257, 221]. Membrane wrapping in
concert with lipid headgroup organization via multi-dentate hydrogen bonding produce the
requisite negative and positive curvature strains, respectively, to permeabilize membranes
by generating topologically active negative Gaussian (equivalently saddle-splay) curvature.
Since positive curvature strain by lipid headgroup organization depends on the spatial
arrangement and coordination of the guanidinium groups, varying these parameters should
affect the curvature generating abilities of guanidine-rich molecules. The first part of this
chapter investigates saddle-splay curvature generation by guanidine homopolymers of differ-
ent lengths and average monomer spacings. We use small-angle x-ray scattering to character-
ize the membrane curvature deformation modes produced by polyguanidine-oxanobornene
homopolymers (PGONs) (Figure 5.1), a synthetic class of molecular transporters with similar
features to arginine-rich cell-penetrating peptides [258]. The presentation of the guanidinium
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Figure 5.1: The polymers used in this study. Left: the polyguanidine-oxanobornene ho-
mopolymer (PGON). Middle: phenyl-guanidine random copolymer (phenyl-GON). Right:
butyl-guanidine random copolymer (butyl-GON). Used with permission from M. Lis.
groups in PGON polymers and poly-arginine CPPs differ owing to their different backbones.
We conduct a detailed investigation on the polymer length dependence of saddle-splay curva-
ture generation by PGON and compare the trends with similar experiments on poly-arginine.
We find that both polymers generate maximum saddle-splay curvature at intermediate de-
gree of polymerization, and the number of repeating units required for maximal saddle-splay
curvature depends on inter-guanidine spacing.
Amphipathic arginine-rich peptides are commonly deployed as antimicrobial agents in the
host defense. Collectively, the sequences of antimicrobial peptides follow the saddle-splay
curvature selection rule (see Chapter 3): the functional requirement of generating saddle-
splay curvature constrains the arginine, lysine, and hydrophobic content in the form of a
compositional trade-off between the relative amounts of arginine and lysine plus hydropho-
bicity used in a peptide. The amino acid compositions of cell penetrating peptides also
follow the saddle-splay curvature selection rule (Figure 5.2) [259]. However, on average the
antimicrobials use greater amounts of hydrophobicity. This implies that a cell-penetrating
peptide can be turned into an antimicrobial by systematically increasing its hydrophobic-
ity. The second part of this chapter investigates how the inclusion of hydrophobic residues
into a guanidine-rich polymer affects its curvature generating abilities. Amphiphilic phenyl-
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Figure 5.2: The saddle-splay curvature selection rule, the trade-off between arginine
with lysine plus hydrophobicity in a peptide, is observed in the sequences of both cell-
penetrating peptides and antimicrobial peptides. In general, as the average hydrophobicity,
〈Hydrophobicity〉, of a membrane-active antimicrobial or cell-penetrating peptide increases
the number of arginines it uses, NR, decreases relative to the number of lysines, NK . The cell-
penetrating peptides are less hydrophobic than the antimicrobial peptides. Figure adapted
from [259]
guanidine and butyl-guanidine random copolymers (Figure 5.1) were chosen since their mem-
brane activities depend on degree of polymerization and on the ratio of monomeric species
instead of their precise arrangement. Therefore, they are an ideal choice for examining the
net effects of adding hydrophobicity to polyguanidine polymers. Small angle x-ray scat-
tering is used to compare the membrane curvature deformations produced by amphiphilic
phenyl- and butyl-guanidine polymers with those produced by PGON polymers of similar
lengths. In general, incorporation of hydrophobicity into a guanidine-rich polymer enhances
its saddle-splay curvature generating ability.
100
5.2 Results and Discussion
5.2.1 PGONs generate negative Gaussian curvature in a manner
dependent on polymer degree of polymerization
PGON polymers were incubated with small unilamellar vesicles (SUVs), lipid composition
DOPS/DOPE = 20/80, to mimic the rich anionic and negative spontaneous curvature lipid
content of Gram-negative bacterial plasma membranes. PGON remodeled the SUVs into
strongly scattering liquid crystalline structures as indicated by the appearance of multiple
structure factor correlation peaks. Representative spectra for PGON polymers with average
degree of polymerization 〈N〉 = 7, 18, 50 are shown in Figure 5.3A. For each polymer the
scattering spectra contain peaks with Q positions at ratio
√
2 :
√
3 :
√
4, indicating the
presence of Pn3m ‘double-diamond’ cubic phases. The Pn3m is a bicontinuous cubic phase
where two non-intersecting tetrahedral water channels are separated by the lipid bilayer.
The midpoint of the bilayer traces out a minimal surface which has zero mean curvature and
negative Gaussian curvature at every point. Geometrically, minimal surfaces locally have the
shape of a saddle; the surface will curve maximally upward and downward in perpendicular
directions. Negative Gaussian curvature is ubiquitous in membrane destabilization processes.
It is present in the interior of toroidal pores, as well as at the base of blebs and the ‘neck’
of budding events, all processes which destabilize and disrupt the barrier function of cell
membranes. By relating the measured peak Q positions to their Miller indices h, k, l,
for each reflection using the equation for a powder averaged cubic phase, i.e. Qmeas =
2pi
√
(h2 + k2 + l2)/a, we calculate lattice parameters a〈N〉=7 = 15.98nm, a〈N〉=18 = 14.98nm,
and a〈N〉=50 = 17.99nm. Cubic phases were observed in PE-rich membranes for PGONs with
〈N〉 = 7, 9, 14, 18, 27, and 50, implying that generation of negative Gaussian curvature is
a general feature of PGON polymers with 〈N〉 = 7-50.
The relationship between PGON length and cubic phase lattice parameter is non-monotonic
(Figure 5.3A&B). A similar trend was previously seen for poly-arginine [259]. Since the
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Figure 5.3: PGON polymer generation of negative Gaussian curvature depends on average
polymer length and average spacing between monomers. A. Representative scattering spec-
tra of PGONs with degree of polymerization 7, 18, & 50 (top to bottom) with DOPS/DOPE
= 20/80 membranes at the polymer to lipid isoelectric point. Arrows indicate the first or-
der reflection of the Pn3m cubic phase. A first order reflection at higher Q indicates the
generation of greater negative Gaussian curvature. B. Plots of polymer-induced average
negative Gaussian curvature generation, −〈K〉, versus polymer length for both PGON and
poly-arginine at the isoelectric point. The maximum amount of −〈K〉 occurs around Arg9
for poly-arginine, while for PGON it is around an average degree of polymerization of 14.
C. Schematic showing structural features of PGON and poly-arginine, and effective spacing
between guanidine groups.
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minimal surface of a cubic phase has average negative Gaussian curvature (equation 1.9)
〈K〉 = 2piχ/a2A0, where a is the cubic lattice parameter, χ is the Euler characteristic, and
A0 is the surface area per unit cell, the measured cubic lattice parameters can be used to
extract the 〈K〉 values for PGON polymers of different lengths. The results are plotted in
Figure 5.3B, along with the data from a similar analysis for poly-arginine. Both PGON
and poly-arginine generate maximum −〈K〉 at intermediate polymer lengths. However, the
polymer length where maximum −〈K〉 occurs for poly-arginine is around Arg9, whereas for
PGON the maximum is shifted outward to an average degree of polymerization of about 14.
Since both PGON and poly-arginine consist solely of guanidine side-chains the differences
in 〈K〉 versus polymer length must originate from the different structural properties of their
backbones which necessarily influence how the guanidinium groups interact with membrane
lipids.
Figure 5.3C shows the structures of PGON and poly-arginine. Polymerization of guani-
dinylated oxanorbornene monomers produces a guanidinium spacing of 5.8A˚, approximately
60% larger than the 3.6A˚ spacing in poly-arginine. The larger spacing in PGON along with
its more shape-persistent scaffold compared to poly-arginine reveal that the average distance
between guanidine side chains will be greater in PGON than poly-arginine [258]. As stated
above saddle-splay curvature generation by guanidinium groups is the product of membrane
wrapping to produce negative curvature and membrane buckling from multi-dentate hy-
drogen bonding with lipid headgroups to produce positive curvature. Membrane buckling
occurs from the cooperative effort of multiple guanidinium groups. Increasing the average
distance between guanidinium groups has the effect of relieving some of the membrane posi-
tive curvature strain. Since negative Gaussian curvature requires both positive and negative
curvature a reduction in positive curvature will also reduce the amount of negative Gaussian
curvature a polymer can generate. In principle, this can be compensated by increasing the
polymer length, so that more guanidinium groups are concentrated in the area. However, the
ability of the guanidinium groups to organize and coordinate lipid headgroups to coopera-
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tively produce positive membrane curvature eventually breaks down. Indeed, polymers with
lengths greater than the optimum value for negative Gaussian curvature generation appear
to antagonize their efforts, since the amount of curvature generated decreases. Therefore, the
stiffer PGON polymer with larger inter-guanidinium spacing requires more repeating units
to maximize its negative Gaussian curvature generation compared with the more flimsy
poly-arginine with its smaller spacing between guanidinium groups.
5.2.2 Incorporation of hydrophobicity into guanidinium-rich
polymers increases the amount of negative Gaussian
curvature they induce in membranes
To examine the effects adding hydrophobicity to guanidinium-rich polymers similar SAXS
experiments were conducted with random copolymers consisting of guanidinium groups with
either hydrophobic butyl or phenyl side chains. A general feature in the scattering spectra
for both butyl-GON (Figure 5.4A) and phenyl-GON (Figure 5.4B) is the strong induction
of the Pn3m cubic phase. At peptide/lipid, P/L = 1/60 molar ratio, sharp correlation
peaks at Q positions with ratios,
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12, are
observed for both butyl-GON and phenyl-GON. By fitting the measured peak Q positions
to their respective reflections via trendline fit (Figure 5.4C&D), we calculate Pn3m cubic
lattice parameters a = 19.40nm for butyl-GON and a = 20.42nm for phenyl-GON at P/L
= 1/60. When the polymer concentration is doubled to P/L = 1/30, similar spectra are
observed (Figure 5.4 A&B). However, the cubic phase reflections have shifted to higher Q
values, indicating greater polymer concentrations induce smaller cubic lattices. At P/L =
1/30 the lattice parameters shrunk to a = 14.38nm for butyl-GON (Figure 5.4C) and a
= 15.42nm for phenyl-GON (Figure 5.4D). The cubic phase lattice parameter is inversely
proportional (see above) to its average negative Gaussian curvature. Therefore, increasing
the polymer concentration increases the amount of membrane negative Gaussian curvature,
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as expected for polymers which generate such curvature. By plotting the average negative
Gaussian curvature over a range of peptide to lipid ratios for polymers with similar lengths
and net charge (Figure 5.4E), their abilities to generate curvature can be directly compared.
Interestingly, −〈K〉 seems to increase linearly with polymer concentration over the range
tested. Furthermore, while roughly equivalent amounts of −〈K〉 were generated by butyl-
GON and phenyl-GON, both amphiphilic polymers consistently generated more −〈K〉 than
the 〈N〉 = 7, and 9 PGON polymers. Therefore, the net effect of adding hydrophobicity
to guanidinium-rich polymers is to increase the amount of negative Gaussian membrane
curvature they induce.
5.2.3 Incorporation of hydrophobicity into guanidinium-rich
polymers broadens the range of lipid compositions where
they induce negative Gaussian curvature
Our previous results on defensins showed that negative Gaussian curvature generation was
highly sensitive to lipid compositions, specifically the concentration of negative spontaneous
curvature lipids in the membrane. To test the effects of reducing membrane DOPE content
on the curvature generating abilities of guanidinium-rich polymers we constructed ternary
DOPS/DOPE/DOPC vesicles. By changing the relative amounts of zwitterionic DOPC
(spontaneous curvature, c0 = 0) and DOPE (c0 < 0) while holding constant the amount of
anionic DOPS (c0 = 0) the amount of negative spontaneous curvature lipids in the mem-
brane can be varied at constant membrane charge density. The results are summarized in
Figure 5.5. In DOPS/DOPE/DOPC = 20/70/10 membranes at P/L = 1/30 both butyl-
GON and phenyl-GON generated Pn3m cubic phases with lattice parameters a = 20.51nm
and a = 20.02nm, respectively (Figure 5.5A). These cubic lattices are larger than the ones
observed for both polymers in 80% PE membranes, demonstrating that negative Gaussian
curvature is more difficult to generate in membranes with lowered concentrations of DOPE
105
Figure 5.4: Hydrophobicity increases the amount of negative Gaussian curvature generated
by guanidinium-rich polymers. A. The butyl-GON polymer, 〈N〉 = 11, butyl/guanidine
molar ratio = 6/5.5, generated Pn3m cubic phases in DOPS/DOPE = 20/80 membranes at
peptide/lipid = 1/60 & 1/30 molar ratios. The arrow points to the first (110) reflection of
the Pn3m, which shifts to higher Q for greater P/L ratios. B. A similar trend is observed for
phenyl-GON polymer, 〈N〉 = 11, phenyl/guanidine molar ratio = 5.5/5.5. C. & D. Indexa-
tion of the Pn3m phase lattice parameters for butyl-GON and phenyl-GON. Smaller lattices
are seen for greater P/L ratios, indicating that increasing polymer concentrations produce
greater amounts of negative Gaussian curvature. At a given P/L the lattice parameter for
butyl-GON and phenyl-GON are close in size. E. Average negative Gaussian curvature,
−〈K〉, generated versus polymer/lipid charge ratios for polymers of similar charges and
sizes. An approximately linear increase in −〈K〉 with increasing polymer concentration is
observed for each polymer. The hydrophobic butyl-GON and phenyl-GON tend to induce
greater −〈K〉 than the hydrophilic PGONs.
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Figure 5.5: Hydrophobicity broadens the range of lipid compositions where guanidinium-rich
polymers induce negative Gaussian curvature. A. Amphiphilic butyl-GON and phenyl-GON
polymers both generated Pn3m cubic phases in membranes with reduced amounts of negative
spontaneous curvature lipids, DOPS/DOPE/DOPC = 20/70/10. Inset shows indexation of
the Pn3m cubic for both polymers. The lattice parameters for butyl-GON, a = 20.51nm,
and phenyl-GON, a = 20.02nm, are approximately equivalent. B-E. Phase diagrams for
guanidinium-rich polymers over a range of lipid compositions, DOPS/DOPE/DOPC =
20/x/(80-x) where x = %DOPE, and peptide/lipid ratios. The amphiphilic butyl-GON
and phenyl-GON polymers generate cubic phases over a larger region of the phase diagram
compared with the hydrophilic PGON polymers.
lipids. Further reducing the amount of negative spontaneous curvature lipids to 60% DOPE
quashes cubic phase generation for both amphiphilic polymers (Figure 5.5B&C). Instead,
pure lamellar phases are observed, which consist of stacks of flat membranes with zero cur-
vature. Comparison of the phase diagrams for butyl-GON (Fig 5.5B) and phenyl-GON
(Figure 5.5C) with the phase diagrams for 〈N〉 = 7 and 9 PGON (Figure 5.5D&E) reveal
that, in general, the addition of hydrophobicity into guanidinium-rich polymers promotes
saddle-splay curvature generation. Cubic phases are observed over a wider region of the
phase diagram for the amphiphilic polymers, and they require less membrane PE content to
generate negative Gaussian curvature.
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Why does adding hydrophobicity to guanidinium-rich polymers enhance their negative
Gaussian curvature generation abilities? The saddle-splay curvature selection rule states that
the arginine content of a peptide can be replaced by a combination of lysine and hydropho-
bicity. The guanidino group of arginine generates negative Gaussian curvature while the
amino group of lysine generates negative curvature only and hydrophobicity generates pos-
itive curvature. However, while poly-guanidinium polymers generally induce both positive
and negative curvature, the amounts of each type of curvature may not be equivalent. Since
incorporating hydrophobicity into PGON polymers enhances their generation of saddle-splay
curvature, this implies PGON polymers induce less positive curvature than negative curva-
ture. Adding hydrophobicity effectively makes up the difference resulting in an amphiphilic
polymer with better membrane destabilizing activity. In the extreme case of positive cur-
vature starved polymers such as poly-lysine which generate negative mean curvature only,
even greater amounts of hydrophobicity are required. Therefore, while multi-dentate hydro-
gen bonding by poly-guanidinium polymers is a sufficient mechanism to buckle membranes
and contribute to saddle-splay curvature generation, its effect is weaker than the positive
curvature strain produced by hydrophobicity.
5.3 Conclusion
In summary we have shown that synthetic polyguanidine-oxanobornene homopolymers,
(PGONs), and amphiphilic phenyl-guanidine and butyl-guanidine random copolymers all
generate negative Gaussian curvature in membranes enriched with anionic lipids and nega-
tive spontaneous curvature lipids. The amount of curvature generated by PGON polymers
was shown to be length dependent with maximal negative Gaussian curvature generation
occurring at intermediate polymer lengths, similar to the trend observed for poly-arginine.
The polymer length that maximizes negative Gaussian curvature generation for PGON is
longer than poly-arginine. The larger spacing between guanidine side chains in PGON and
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its stiffer backbone lessen the positive curvature strain due to multi-dentate hydrogen bond-
ing so more guanidinium groups are necessary to compensate. Incorporation of hydrophobic
butyl and phenyl groups into guanidinium-rich polymers increased the amount of negative
Gaussian curvature they generate as well as broadened the range of lipid compositions over
which it was observed. This implies that adding hydrophobicity to guanidinium-rich poly-
mers enhances their negative Gaussian curvature generating abilities by supplying additional
positive curvature to help balance the unequal amounts of positive and negative curvature
produced by the guanidinium groups. For 1:1 guanidine:hydrophobe polymers negligible
differences between the curvature generating abilities of the hydrophobic butyl and phenyl
moieties were observed. We believe these results will help guide the design of cell-penetrating
peptides and membrane-active antimicrobials.
5.4 Materials and Methods
5.4.1 Liposome preparation for x-ray measurements, and SAXS
experiments
Liposomes were prepared as described in section 3.2.2. X-ray samples were prepared and
measured as described in section 3.2.3 except for the following changes. All samples were
prepared in 100mM NaCl solution. SAXS experiments at synchrotron sources were collected
at Stanford Synchrotron Radiation Laboratory (BL4- 2), the Advance Light Source (ALS)
(beamline 7.3.3). The scattered radiation was collected using a Rayonix MX225-HE detector
(pixel size, 73.2µm) at SSRL and a Pilatus 100k detector (pixel size, 172µm). Samples were
also measured at the CNSI at UCLA using an in house setup. A compact SAXS light source
(Forvis Technologies, Inc.) was used in conjunction with a mar345 image plate detector
(pixel size, 150µm).
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Chapter 6
Outlook
6.1 Introduction
This thesis has focused on the types of curvature antimicrobial peptides generate in lipid
membranes. Since a general mechanism of action for antimicrobial peptides is membrane
disruption their fundamental structural motif, cationicity and hydrophobicity, is constrained
by the topological requirement that they induce saddle-splay membrane curvature. The
global trend in the arginine, lysine, and hydrophobic content of antimicrobial peptides and
cell-penetrating peptides is the result of this constraint. The saddle-splay curvature selection
rule provides a detailed molecular explanation for the observed trend.
Are there trends within the global trend? The complementary curvature generating
abilities of lysine and hydrophobicity implies there is a positive correlation between them.
However, could their be a more intricate relationship between the commonly classified hy-
drophobic amino acids: leucine, isoleucine, valine, methionine, alanine, phenylalanine, tryp-
tophan, and the cationic amino acids lysine and arginine? In the first section of this chapter
we sketch a possible answer.
Is it possible that the cationic and hydrophobic structural motif is employed in other
biological systems to generate membrane curvature? This appears to be the case. A brief
review of other cationic amphipathic molecules that generate membrane destabilizing curva-
tures is provided in the opening part of the second section. Are there other structural motifs
which render molecules membrane-active? Again the answer is yes. A brief discussion of our
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current research on an amphipathic motif distinct from the one found in AMPs concludes
the second section. This different motif generates a different type of membrane curvature.
6.2 Correlations between amino acids in AMPs
Sample Pearson product-moment correlation coefficients, ρ’s, are calculated to determine the
degree of association between two different amino acids in AMPs sequences (see Materials
and Methods). The results are shown in Figure 6.1. Lysine shows positive correlations with
the hydrophobic amino acids alanine, leucine, isoleucine, and methionine, whereas arginine
is anti-correlated with them (Figure 6.1A). While the negative correlation between arginine
and hydrophobic amino acids may be a partial consequence of the larger negative correlation
between lysine and arginine (Figure 6.1C), the message is unchanged: the presence of lysine
over arginine tends to be accompanied by a greater proportion of hydrophobic amino acids, in
agreement with the saddle-splay curvature selection rule. The significant exception is for the
aromatic amino acid phenylalanine which is positively correlated with arginine and negatively
correlated with lysine (Figure 6.1A). Furthermore, arginine is also positively correlated with
tyrosine, another aromatic, while lysine shows a negative correlation with this amino acid
(Figure 6.1B). Despite the small overall correlations, probably due to the great sequence
diversity of membrane active AMPs, notable trends emerge.
Interestingly, studies in the complementary field of transmembrane proteins have shown
that the energetically most favorable position for aliphatic residues alanine, leucine, isoleucine,
and valine is at the center of the membrane, while the aromatic residues tyrosine and tryp-
tophan prefer the membrane-water interface [229, 260], in agreement with amino acid distri-
butions in transmembrane α-helices from integral membrane proteins [261]. Therefore, there
may be a correspondance between AMPs that use aliphatic or aromatic amino acids and how
deep they embed into the non-polar region of the bilayer. A future direction of this research
will be to investigate the significance of the co-correlations between lysine and aliphatic
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Figure 6.1: Correlation coefficients from 1080 AMP sequences show positive correlation be-
tween lysine and the hydrophobic aliphatic amino acids, while arginine is positively correlated
with aromatic amino acids. A. Overall, lysine is positively correlated with the hydrophobic
amino acids while arginine is negatively with them. B. Positive (negative) correlation be-
tween arginine (lysine) and aromatic amino acids. C. Cationic amino acids show negative
correlations.
residues and between arginine and aromatic residues in terms of curvature generation.
6.3 Other natural amphipathic curvature generators
Membrane curvature results from non-specific electrostatic and hydrophobic interactions be-
tween lipid membranes and cationic, amphipathic molecules. Therefore, membrane-associating
peptides or proteins which contain domains with similar motifs as AMPs should generate
similar types of membrane curvature. For example, section 3.4 mentioned the M2 pro-
tein from the influenza virus contains an amphipathic α-helix with similar composition to
AMPs, that is capable of inducing budding in vesicles. During viron release the M2 protein
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localizes at the neck of budding virons, the site of maximal negative Gaussian curvature
[240]. Other examples are found in proteins that modify membrane curvature for endocytic
mechanisms. The epsin-1 protein promotes membrane invagination and has been impli-
cated in clathrin-mediated endocytosis. Epsin-1 contains a highly conserved lipid binding
N-terminal ENTH domain. Upon binding PtdIns(4,5)P2, an amphipathic α-helix is formed
in this domain which inserts into the membrane and generates curvature. Furthermore,
both epsin-1 and the ENTH domain tubulated liposomes [262, 226]. Certain BAR domains
such as those found in amphiphysins and endophilins contain amphipathic α-helices at their
N-terminus. An amphipathic α-helix in these N-BAR domains inserts into the membrane
and acts as a molecular wedge inducing curvature along the concave surface of the BAR
domain [263, 264, 265, 266]. Curvature generation by N-BAR domains has been proposed
to be an important biophysical mechanism for vesicle budding [226, 265]. Other amphi-
pathic sequences have been implicated as curvature sensors. Studies on the Golgi-associated
protein ArfGAP have shown it preferentially absorbs onto membranes with strong positive
curvature via a membrane associated amphipathic α-helix containing a weakly charged polar
face [267, 268]. Evidently, reducing the positive charge in cationic, amphipathic molecules
changes them from membrane curvature generators to curvature sensors. Taken together,
these results indicate that the cationic, amphipathic structural motifs seen in AMPs are
similarly employed by membrane remodeling proteins to generate controlled membrane cur-
vature for a variety of important biological processes.
6.3.1 Amphipathic α-helices from apolipoproteins
In addition to the cationic versions mentioned above, other amphipathic helix motifs are
commonly found in peptides and proteins [269]. One motif found in many apolipoproteins,
the protein components of plasma lipoproteins, has attracted wide interest due its central
role in atheroschlerosis. Complications of atherosclerosis, the thickening of artery walls due
to the buildup of fatty materials such as cholesterol, are the leading cause of death in Western
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societies [270]. Studies have demonstrated that high levels of high density lipoprotein (HDL)
are inversely correlated with atherosclerotic events related to cardiovascular disease [271].
Plasma lipoproteins such as HDL consist of an outer layer of phospholipids, apolipoproteins,
and cholesterol, and inner core of primarily cholesterol esters and triglycerides (Figure 6.2A).
The main apolipoprotein of HDL, apoA-I, plays a critical role as apo A-I binds increasing
amounts of cholesterol and phospholipids enlarging the HDL particle. The lipid-rich HDL
are subsequently transported to the liver where cholesterol can be removed from circulation
[272].
ApoA-I is a 243 amino acid protein that contains a series of amphipathic α-helical repeats
which are responsible for its lipid associating properties [273] (Figure 6.2B). By mimicking
the amphipathic helical motif in apoA-I, peptide mimetics of apoA-I have been synthesized
as therapeutic agents to improve upon HDL function and reduce levels of atherosclerosis.
The 4F peptide (aka D4F or L4F, based on the enantiomer used) is an 18 amino acid peptide
whose sequence is based on the eight 22-mer α-helices in apolipoprotein ApoA-1 [271]. Like
the parent ApoA-1 protein the 4F peptide displayed similar lipid restructuring properties
[271] as well as good anti-inflammatory [274] and anti-atherogenic abilities [275].
The motif of the ApoA-1 derived 4F peptide differs from membrane lytic antimicrobial
peptides on the polar face of the α-helix. The polar face of AMPs simply consists of a high
proportion of cationic amino acids and polar residues (Figure 6.3). However, The polar face
of the 4F peptide is decorated with anionic residues in the middle, whereas the cationic
residues are placed near the polar-apolar interface (Figure 6.3). Therefore, while α-helical
AMPs typically have net positive charge in the +4 to +9 range, the 4F peptide has zero net
charge. The intricate arrangement of charged residues on the polar face along with zero net
charge cause the 4F peptide to induce a dramatically different type of curvature than the
antimicrobial peptides.
In this section we briefly discuss some current research on the interaction of the 4F
peptide with lipid membranes. In general, the 4F peptide generates membrane positive
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Figure 6.2: Apolipoproteins found in high density lipoprotein (HDL) contain amphipathic
α-helices. A. HDL particles vary between 7-16nm in size, and are composed of an inner
hydrophobic core of cholesterol esters and triglycerides, surrounded by an outer layer of
phospholipids, sterols, and apolipoproteins. B. Structure of C-terminal domain of human
apolipoprotein apoA-I (residues 44-243). This domain is predicted to contain eight 22-mer
and two 11-mer amphipathic α-helices. C. Helical wheel projection of an ApoA-I consensus
peptide: the 4F peptide. Sequence: KWFDAFYKDVAKEFEKAF. Anionic amino acids are
colored red, cationic residues are blue, and hydrophobic residues are yellow. Illustration in
A is from [276]. B is adopted from [277]
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Figure 6.3: Helical wheel projections of the 4F peptide, melittin, and magainin-2. The struc-
tural motif of the 4F peptide differs from the α-helical antimicrobial peptides. Both classes
are amphipathic. Differences in the distribution of charge on their polar faces affect their
membrane deformation properties. Anionic amino acids are colored red, cationic residues
are blue, hydrophobic residues are yellow, and polar residues are teal.
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Gaussian curvature. This is not too surprising. The 4F peptide is a mimic of a protein
which helps model spheroidal HDL particles. However, since positive Gaussian curvature
is antagonistic to negative Gaussian curvature, the 4F peptide has the ability to ‘turn off’
membrane destabilizing peptides like AMPs. Small angle x-ray scattering is used to show
that the 4F peptide quashes cubic phase formation by the antimicrobial peptide protegrin-1.
These results are consistent with dye leakage experiments where treatment of vesicles with
4F peptide drastically reduces the ability of melittin to permeabilize membranes.
6.3.2 The D4F peptide does not restructure model liposomes
Small unilamellar vesicles (SUVs) with lipid composition DOPS/DOPE = 20/80 were incu-
bated with D4F. SAXS profiles from the lipid solutions only show a broad feature from the
form factor from an isolated lipid bilayer consistent with small unilamellar vesicles (Figure
6.4A). The same feature is observed when D4F is introduced (Figure 6.4A) indicating that
D4F does not substantially restructure SUVs under these conditions1. This phase behavior
is strikingly different to the substantial restructuring of DOPS/DOPE = 20/80 vesicles by
membrane destabilizing antimicrobial peptides. Both melittin (Figure 6.4B) and magainin-
2 (Figure 6.4C) generated the Pn3m cubic phase in membranes enriched with anionic and
negative spontaneous curvature lipids. Therefore, unlike AMPs which generate negative
Gaussian curvature, the D4F peptide did not deform membranes away from their (locally)
flat native state.
1Restructuring liposomes into the discoidal or spheroidal particles commonly associated with lipoproteins
requires much higher (> 1/5) peptide to lipid molar ratios. Furthermore, pure PC lipids are almost always
used to make these particles.
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Figure 6.4: Apolipoprotein mimic peptide D4F did not restructure model bacteria mem-
branes A. SAXS scattering spectra from DOPS/DOPE = 20/80 membranes only (black
curve) are practically identical to those from membranes treated with D4F (green and teal
curves). D4F/Lipid ratios are in moles. Under similar solution conditions membrane lytic
antimicrobial peptides melittin, B, and magainin-2, C, restructured DOPS/DOPE = 20/80
membranes into Pn3m cubic phases with lattice parameters 18.2nm and 17.9nm, respec-
tively. Insets show indexing of the cubic peaks. Peptide to lipid molar ratios are 1/40 for
melittin and 1/60 for magainin-2. SAXS spectra in B&C are the same as in Figure 3.10.
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6.3.3 The L4F peptide drastically reduces membrane
permeabiliztion by melittin
To understand the effects of 4F peptides on membrane integrity large unilamellar vesi-
cles (LUVs) were loaded with calcein dye and treated with L4F, and the dye leakage was
monitored using fluorimetry as a function of time. The leakage profile for L4F was indis-
tinguishable from the background (Figure 6.5). This behavior differs substantially from the
behavior of melittin, the principle component of European honey bee venom [230]. Melittin
is a 26 amino acid peptide with potent membrane disruption activity against both eukaryotic
cells and bacteria [231, 232, 233]. Good dye leakage (> 80%) was evident after exposure to
melittin, consistent with its strong membrane permeabilizing ability (Figure 6.5). However,
when melittin was added to vesicle solutions pre-treated with L4F, an eight fold reduction
of leakage (< 10%) was observed relative to the melittin only case (see Materials and Meth-
ods). The strong reduction of leakage indicates the 4F peptides can render membranes more
resistant to permeabilization by inhibiting the mode of action of membrane lytic peptides.
6.3.4 The D4F peptide antagonizes negative Gaussian curvature
generation by protegrin-1
To examine the effects of D4F on the membrane restructuring abilities of lytic peptides
SUVs were co-incubated with a constant concentration of protegrin-1 (PG1), and varying
concentrations of the D4F peptide. Protegrin-1 is an 18 amino acid cathelicidin originally
isolated from porcine leukocytes, which displays potent broad spectrum activity against both
Gram positive and Gram negative bacteria, but also shows hemolytic activity toward hu-
man erythrocytes [74, 124]. In the absence of D4F, PG1 restructured DOPS/DOPE = 20/80
vesicles into coexisting Pn3m cubic and inverted hexagonal phases with lattice parameters
aPn3m = 21.6nm and aHII ∼ 7.5nm, respectively (Figure 6.6A&C). Therefore, PG1 gener-
ated both negative Gaussian curvature and negative mean curvature in model bacteria cell
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Figure 6.5: The leakage of dye from LUVs due to melittin exposure is inhibited by L4F. In
vesicles with lipid composition DOPS/DOPE/DOPC = 20/60/20 melittin induced good dye
leakage (purple curve), while negligible leakage was seen with L4F (red curve). When both
melittin and D4F are present much less leakage occurred (green curve) than with melittin
only. Peptide to lipid ratios are 1/15 for D4F and 1/50 for melittin. See Materials and
Methods for details.
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Figure 6.6: The D4F peptide turned off the negative Gaussian curvature and negative Mean
curvature generated by the antimicrobial peptide protegrin-1 (PG1). A. At peptide/lipid =
1/70, PG1 generated coexisting Pn3m cubic and inverted hexagonal phases in DOPS/DOPE
= 20/80 membranes. The ‘double-peak’ feature of the inverted hexagonal phase implies this
sample may not be completely at equilibrium. When D4F is present only lamellar phases
(lattice parameters d = 5.8nm for D4F/Lipid = 1/60, & d = 5.0nm for D4F/Lipid = 1/30)
are observed. B. Schematic explaining that D4F stomps out saddle-splay curvature generated
by PG1. C. Indexation of the Pn3m cubic phase generated by PG1 in DOPS/DOPE = 20/80
membranes.
membranes. Upon addition of the D4F peptide the correlation peaks corresponding to both
the cubic and inverted hexagonal phases disappeared and were replaced by reflections with
ratio, 1:2, indicating the presence of zero curvature lamellar phases (Figure 6.6A). While D4F
is unable to substantially restructure vesicles its membrane interactions inhibit the genera-
tion of negative Gaussian curvature and negative mean curvature by PG1. Since negative
Gaussian curvature is topologically required for membrane destabilization, the effect of D4F
is to stabilize membranes by antagonizing the topologically-active curvature deformations
generated by permeabilizing agents such as membrane lytic peptides (Figure 6.6B).
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6.3.5 Discussion and conclusion
Differences in the polar faces of the 4F peptide and the α-helical membrane lytic antimicro-
bials are responsible for their distinct membrane curvature generating properties. The polar
face of AMPs are usually populated by a large amount of cationic charges. As explained in
Chapter 3, anionic membranes tend to wrap cationic peptides so their interaction generally
produces negative mean curvature. This is complementary to the effect of hydrophobicity
which acts as a molecular wedge and inserts into the membrane to produce positive cur-
vature. Therefore, cationic and hydrophobic AMPs generate both negative and positive
curvature, or negative Gaussian curvature. However, the polar face of the 4F peptide has
zero net charge, and so this peptide does not promote membrane wrapping. Instead, the 4F
peptide generates positive curvature only, or positive Gaussian curvature. Positive Gaussian
curvature generation still requires strong interaction between the peptide and the anionic
membrane. To ensure optimal contact between the 4F peptide and membrane the cationic
amino acids are located around the polar-apolar interface so they can easily interact with
the phosphates and other anionic moieties in lipid headgroups. Placing the anionic amino
acids in the middle of the polar face keeps them further away from the lipid headgroups, but
in an ideal position to electrostatically penalize membrane wrapping.
The contamination of negative Gaussian curvature by positive Gaussian curvature is sum-
marized in Figure 6.7. Saddle-splay curvature deformations can cooperate to produce pores
leading to the loss of barrier function of cell membranes (Figure 6.7A). Existing theoretical
work supports the idea that anisotropic saddle-splay curvature defects attract each other
[224, 278] and can stabilize pore structures in membranes [225]. However, when positive
Gaussian curvature ‘domes’ are mixed together with saddle-shaped curvature patches the
domes can antagonize pore formation (Figure 6.7B) and therefore reduce permeabilization.
In summary we show that a structural motif from the α-helices in apolipoprotein ApoA-
I generates positive Gaussian curvature in lipid membranes. The specific arrangement of
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Figure 6.7: The synergistic and antagonistic effects of different curvature deformations. A.
Saddle-shaped negative Gaussian curvature deformations combine to tile the interior of a
pore. B. Combining negative Gaussian curvature saddles with positive Gaussian curvature
domes leads to ‘egg-carton’ structures without pores. Figure adopted from [279].
charge on the polar face of the ApoA-I derived 4F peptide leads to strong peptide-membrane
interactions without promoting negative curvature deformations from membrane wrapping.
The molecular mechanisms of positive Gaussian curvature generation by the 4F peptide is
entirely consistent with the molecular mechanisms of negative Gaussian curvature generation
by membrane lytic peptides like AMPs. Since positive Gaussian curvature is antagonistic to
negative Gaussian curvature, the structural motifs similar to those found in the α-helices of
ApoA-I may be used to inhibit unwanted instances of saddle-splay curvature. In addition
to bee stings, possible targets include: the endocytic and exocytic events that are essential
in the replication cycle of enveloped viruses [280], and cell-cell fusion events such as those
which occur during fertilization [281]. Therefore we believe this positive Gaussian curvature
structural motif can be used in the rational design of new therapeutic agents.
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6.4 Materials and Methods
6.4.1 Pearson’s product-moment sample correlation coefficient
calculations
The dataset of 1080 cationic AMPs from Chapter 3 was used for Pearson’s product-moment
sample correlation coefficient analysis. The sample correlation coefficient between the amino
acids X and Y in a dataset of AMPs of size N , is defined
ρXY ≡
N∑
i=1
(Xi − 〈X〉)(Yi − 〈Y 〉)√
N∑
i=1
(Xi − 〈X〉)2
√
N∑
i=1
(Yi − 〈Y 〉)2
(6.1)
where the Xi’s are the number of instances the amino acid X is found in the ith peptide.
The averages are written in the usual way
〈X〉 = 1
N
N∑
i=1
Xi (6.2)
The sequence lengths of antimicrobial peptides differ and this must be taken into account.
Therefore, we want the correlation between amino acids X and Y while controlling for the
effects of sequence length, L. This is known as partial correlation and is defined
ρXY ·L ≡ ρXY − ρXLρY L√
1− ρ2XL
√
1− ρ2Y L
(6.3)
The calculated partial correlation coefficients are plotted in Figure 6.1. All the plotted
correlation coefficients have p-values ≤ 0.05 except the coefficients between: arginine and
histidine (p = 0.2), arginine and tryptophan (p = 0.38), lysine and valine (p = 0.14), &
lysine and tryptophan (p = 0.65). The lack of statistical significance for correlations with
tryptophan and histidine are probably due to their infrequent usage (His constitutes 2.3%
of residues found in AMP sequences while Trp constitutes 1.5%) within the collection of all
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AMPs.
6.4.2 Liposome preparation for x-ray measurements, and SAXS
experiments
Liposomes were prepared as described in section 3.2.2. X-ray samples were prepared and
measured as described in section 3.2.3 except for the following changes. The D4F samples,
and the D4F + protegrin-1 samples were prepared in 100mM NaCl and 10mM Hepes at pH
7.0. For the D4F + protegrin-1 samples both peptides were exposed to liposomes simultane-
ously. SAXS experiments were only collected at Stanford Synchrotron Radiation Laboratory
(BL4- 2). The scattered radiation was collected using a Rayonix MX225-HE detector (pixel
size, 73.2µm).
6.4.3 Fluorimetry experiments
Liposome preparation: DOPS, DOPE, and DOPC were mixed at a 20/60/20 w/w ratio.
The solution was dried under N2 and desiccated under vacuum overnight. The dried lipids
are rehydrated with 1 ml buffer 1 (10mM NaCl, 50mM fluorescein, and 10mM Hepes, at
pH 7.0). The hydrated mixture is incubated at 37◦C for 24 hours. The resultant solution is
freeze-thawed 8 times and extruded 13 times in a mini-extruder through 1 µm polycarbonate
membrane to obtain LUVs. The resulting vesicles are purified by PD-10 desalting column
against buffer 2 (100mM NaCl, 60mM Hepes at pH 7.0). 200ul of vesicle solution is collimated
with 3ml of buffer 2 and only the first band (should be yellowish-red color) is collected into
a glass vial.
Measuring dye leakage by fluorimetry: 20µl of collimated vesicle solution is diluted
to 1600µl with buffer 2 inside a plastic cuvette. Fluorescence intensity is measured by
the fluorimeter (λexc =490nm, λem=520nm, slits set at 1nm × 1nm). Baseline fluorescent
intensity is first established by measuring the fluorescence emitted by vesicles and buffer
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for 180s. Then, 400ul of peptide solution is diluted in buffer 2 (at the desired peptide to
lipid molar ratio) and added to the cuvette. The cuvette is vortexed and placed back into
the fluorimeter. Fluorescence intensity is then measured between 15-60min to obtain a dye
leakage profile. Finally, 2µl of Triton-X detergent is added to the cuvette to get a maximum
fluorescence intensity. The cuvette is vortexed and placed back into the fluorimeter until the
end of the scan. For L4F & melittin samples the LUVs were incubated with L4F peptide
for ∼10min before addition of melittin.
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